BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fan Z, Chen L, Li J, Cheng X, Yang J, Tian C, Zhang Y, Huang S, Liu Z, Cheng J. Clinical Features of COVID-19-Related Liver Functional Abnormality. Clin Gastroenterol Hepatol. 2020;18:1561-1566. [PMID: 32283325 DOI: 10.1016/j.cgh.2020.04.002] [Cited by in Crossref: 284] [Cited by in F6Publishing: 276] [Article Influence: 142.0] [Reference Citation Analysis]
Number Citing Articles
1 Ekpanyapong S, Bunchorntavakul C, Reddy KR. COVID-19 and the Liver: Lessons Learnt from the EAST and the WEST, A Year Later. J Viral Hepat 2021. [PMID: 34352133 DOI: 10.1111/jvh.13590] [Reference Citation Analysis]
2 Przekop D, Gruszewska E, Chrostek L. Liver function in COVID-19 infection . World J Hepatol 2021; 13(12): 1909-1918 [DOI: 10.4254/wjh.v13.i12.1909] [Reference Citation Analysis]
3 Afewerky HK. Pathology and pathogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Exp Biol Med (Maywood) 2020;245:1299-307. [PMID: 32635753 DOI: 10.1177/1535370220942126] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Chowdhury MR, Mas-ud MA, Ali MR, Fatamatuzzohora M, Shimu AS, Haq MA, Islam MA, Hossain MF, Hosenuzzaman M, Islam MM, Hasan MF, Matin MN. Harmful Effects of COVID-19 on Major Human Body Organs: A Review. J Pure Appl Microbiol 2021;15:500-11. [DOI: 10.22207/jpam.15.2.14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Lu Q, Zhu Z, Tan C, Zhou H, Hu Y, Shen G, Zhu P, Yang G, Xie X. Changes of serum IL-10, IL-1β, IL-6, MCP-1, TNF-α, IP-10 and IL-4 in COVID-19 patients. Int J Clin Pract 2021;75:e14462. [PMID: 34107113 DOI: 10.1111/ijcp.14462] [Reference Citation Analysis]
6 Abdulla S, Hussain A, Azim D, Abduallah EH, Elawamy H, Nasim S, Kumar S, Naveed H. COVID-19-Induced Hepatic Injury: A Systematic Review and Meta-Analysis. Cureus 2020;12:e10923. [PMID: 33194489 DOI: 10.7759/cureus.10923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Cui H, Wu F, Fan Z, Cheng X, Cheng J, Fan M. The effects of renin-angiotensin system inhibitors (RASI) in coronavirus disease (COVID-19) with hypertension: A retrospective, single-center trial. Med Clin (Engl Ed) 2020;155:295-8. [PMID: 33043142 DOI: 10.1016/j.medcle.2020.06.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Gurala D, Al Moussawi H, Philipose J, Abergel JR. Acute Liver Failure in a COVID-19 Patient Without any Preexisting Liver Disease. Cureus. 2020;12:e10045. [PMID: 32983735 DOI: 10.7759/cureus.10045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ippolito D, Vernuccio F, Maino C, Cannella R, Giandola T, Ragusi M, Bigiogera V, Capodaglio C, Sironi S. Multiorgan Involvement in SARS-CoV-2 Infection: The Role of the Radiologist from Head to Toe. Diagnostics 2022;12:1188. [DOI: 10.3390/diagnostics12051188] [Reference Citation Analysis]
10 Simabuco FM, Tamura RE, Pavan ICB, Morale MG, Ventura AM. Molecular mechanisms and pharmacological interventions in the replication cycle of human coronaviruses. Genet Mol Biol 2020;44:e20200212. [PMID: 33237152 DOI: 10.1590/1678-4685-GMB-2020-0212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Jiang S, Wang R, Li L, Hong D, Ru R, Rao Y, Miao J, Chen N, Wu X, Ye Z, Hu Y, Xie M, Zuo M, Lu X, Qiu Y, Liang T. Liver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational Study. Front Med (Lausanne). 2020;7:347. [PMID: 32656222 DOI: 10.3389/fmed.2020.00347] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
12 Cheung S, Quiwa JC, Pillai A, Onwu C, Tharayil ZJ, Gupta R. Superior Mesenteric Artery Thrombosis and Acute Intestinal Ischemia as a Consequence of COVID-19 Infection. Am J Case Rep 2020;21:e925753. [PMID: 32724028 DOI: 10.12659/AJCR.925753] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 12.0] [Reference Citation Analysis]
13 Metawea MI, Yousif WI, Moheb I. COVID 19 and liver: An A-Z literature review. Dig Liver Dis. 2021;53:146-152. [PMID: 32988758 DOI: 10.1016/j.dld.2020.09.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
14 Sharma A, Jaiswal P, Kerakhan Y, Saravanan L, Murtaza Z, Zergham A, Honganur NS, Akbar A, Deol A, Francis B, Patel S, Mehta D, Jaiswal R, Singh J, Patel U, Malik P. Liver disease and outcomes among COVID-19 hospitalized patients - A systematic review and meta-analysis. Ann Hepatol. 2021;21:100273. [PMID: 33075578 DOI: 10.1016/j.aohep.2020.10.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
15 Kang SH, Cho DH, Choi J, Baik SK, Gwon JG, Kim MY. Association between chronic hepatitis B infection and COVID-19 outcomes: A Korean nationwide cohort study. PLoS One 2021;16:e0258229. [PMID: 34610052 DOI: 10.1371/journal.pone.0258229] [Reference Citation Analysis]
16 Goel S, Jain T, Hooda A, Malhotra R, Johal G, Masoomi R, Kamran H, Krishnamoorthy PM, Senguttuvan NB, Sharma A, Gidwani U. Clinical Characteristics and In-Hospital Mortality for COVID-19 Across The Globe. Cardiol Ther 2020;9:553-9. [PMID: 32683639 DOI: 10.1007/s40119-020-00189-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
17 Mirzaie H, Vahidi M, Shokoohi M, Darvishian M, Sharifi H, Sharafi H, Karamouzian M. COVID-19 Among Patients With Hepatitis B or Hepatitis C: A Systematic Review. Hepat Mon 2021;20. [DOI: 10.5812/hepatmon.111617] [Reference Citation Analysis]
18 Potere N, Valeriani E, Candeloro M, Tana M, Porreca E, Abbate A, Spoto S, Rutjes AWS, Di Nisio M. Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Crit Care 2020;24:389. [PMID: 32616077 DOI: 10.1186/s13054-020-03022-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 28.0] [Reference Citation Analysis]
19 Licata A, Minissale MG, Distefano M, Montalto G. Liver injury, SARS-COV-2 infection and COVID-19: What physicians should really know? GastroHep 2021;3:121-30. [PMID: 34149320 DOI: 10.1002/ygh2.455] [Reference Citation Analysis]
20 Nasa P, Alexander G. COVID-19 and the liver: What do we know so far? World J Hepatol 2021; 13(5): 522-532 [PMID: 34131467 DOI: 10.4254/wjh.v13.i5.522] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Aldhaleei WA, Alnuaimi A, Bhagavathula AS. COVID-19 Induced Hepatitis B Virus Reactivation: A Novel Case From the United Arab Emirates. Cureus. 2020;12:e8645. [PMID: 32550096 DOI: 10.7759/cureus.8645] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
22 Baroiu L, Dumitru C, Iancu A, Leșe AC, Drăgănescu M, Baroiu N, Anghel L. COVID-19 impact on the liver. World J Clin Cases 2021; 9(16): 3814-3825 [PMID: 34141738 DOI: 10.12998/wjcc.v9.i16.3814] [Cited by in CrossRef: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Ji P, Chen J, Golding A, Nikolov NP, Saluja B, Ren YR, Sahajwalla CG. Immunomodulatory Therapeutic Proteins in COVID-19: Current Clinical Development and Clinical Pharmacology Considerations. J Clin Pharmacol 2020;60:1275-93. [PMID: 32779201 DOI: 10.1002/jcph.1729] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Vespa E, Pugliese N, Piovani D, Capogreco A, Danese S, Aghemo A;  Humanitas Covid-19 Task Force. Liver tests abnormalities in COVID-19: trick or treat? J Hepatol. 2020;73:1275-1276. [PMID: 32473194 DOI: 10.1016/j.jhep.2020.05.033] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
25 Gök S, Bahçecioğlu ÖF, Durmuş M, Gün ZÜ, Ersoy Y, Aytemur ZA, Ulutaş Ö. The safety profile of favipiravir in COVID-19 patients with severe renal impairment. Int J Clin Pract 2021;:e14938. [PMID: 34605126 DOI: 10.1111/ijcp.14938] [Reference Citation Analysis]
26 Sikkema BJB, Sint Nicolaas JJ, van Wijngaarden PP. No association between COVID-19 related liver injury and the course of disease: a retrospective study. Scand J Gastroenterol 2021;56:68-71. [PMID: 33119428 DOI: 10.1080/00365521.2020.1842489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Makarem J, Naghibi N, Beigmohammadi MT, Foroumandi M, Mehrpooya M. A Case Report of Progressive Liver Failure Inappropriate to Decompensated Heart Failure Following Infection With COVID-19. Cureus. 2020;12:e10142. [PMID: 33014641 DOI: 10.7759/cureus.10142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Zhong P, Xu J, Yang D, Shen Y, Wang L, Feng Y, Du C, Song Y, Wu C, Hu X, Sun Y. COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms. Signal Transduct Target Ther 2020;5:256. [PMID: 33139693 DOI: 10.1038/s41392-020-00373-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 17.5] [Reference Citation Analysis]
29 Bzeizi K, Abdulla M, Mohammed N, Alqamish J, Jamshidi N, Broering D. Effect of COVID-19 on liver abnormalities: a systematic review and meta-analysis. Sci Rep 2021;11:10599. [PMID: 34012016 DOI: 10.1038/s41598-021-89513-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
30 Chadalavada P, Padbidri V, Garg R, Alomari M, Babar A, Kewan T, Ahuja KR, Contreras J, Al-Jaghbeer MJ, Sanaka MR. Transaminases are Potential Biomarkers of Disease Severity in COVID-19 Patients: A Single-Center Experience. Cureus 2020;12:e11555. [PMID: 33365223 DOI: 10.7759/cureus.11555] [Reference Citation Analysis]
31 Bilal M, Sawhney MS, Feuerstein JD. Coronavirus disease-2019: implications for the gastroenterologist. Curr Opin Gastroenterol 2021;37:23-9. [PMID: 33074995 DOI: 10.1097/MOG.0000000000000694] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
32 Escalante HDLL, Hasan N, Delgado A, Soto S, Vivas JG. A group of homoeopathic medicines for COVID-19: A systematic review of clinical features. Indian J Res Homoeopathy 2021;15:123. [DOI: 10.4103/ijrh.ijrh_106_20] [Reference Citation Analysis]
33 Wiśniewska H, Skonieczna-Żydecka K, Parczewski M, Niścigorska-Olsen J, Karpińska E, Hornung M, Jurczyk K, Witak-Jędra M, Laurans Ł, Maciejewska K, Socha Ł, Leonciuk A, Bander D, Karasińska-Cieślak M, Aksak-Wąs B, Wawrzynowicz-Syczewska M. Hepatotropic Properties of SARS-CoV-2-Preliminary Results of Cross-Sectional Observational Study from the First Wave COVID-19 Pandemic. J Clin Med 2021;10:672. [PMID: 33572429 DOI: 10.3390/jcm10040672] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
34 Elnaggar M, Abomhya A, Elkhattib I, Dawoud N, Doshi R. COVID-19 and liver diseases, what we know so far. World J Clin Cases 2022; 10(13): 3969-3980 [DOI: 10.12998/wjcc.v10.i13.3969] [Reference Citation Analysis]
35 Coni P, Pichiri G, Lachowicz JI, Ravarino A, Ledda F, Fanni D, Gerosa C, Piras M, Coghe F, Gibo Y, Cau F, Castagnola M, Van Eyken P, Saba L, Piludu M, Faa G. Zinc as a Drug for Wilson's Disease, Non-Alcoholic Liver Disease and COVID-19-Related Liver Injury. Molecules 2021;26:6614. [PMID: 34771023 DOI: 10.3390/molecules26216614] [Reference Citation Analysis]
36 Li G, Xu Y, Yang YT, Liu PF. Prevalence of acute liver injury and hypertransaminemia in patients with COVID-19: a protocol for a systematic review. BMJ Open 2020;10:e040517. [PMID: 32641369 DOI: 10.1136/bmjopen-2020-040517] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Naz S, Zahoor M, Sahibzada MUK, Ullah R, Alqahtani AS. COVID-19 and SARS-CoV-2: Everything we know so far – A comprehensive review. Open Chemistry 2021;19:548-75. [DOI: 10.1515/chem-2021-0049] [Reference Citation Analysis]
38 Charan J, Bhardwaj P, Dutta S, Kaur R, Bist SK, Detha MD, Kanchan T, Yadav D, Mitra P, Sharma P. Use of Complementary and Alternative Medicine (CAM) and Home Remedies by COVID-19 Patients: A Telephonic Survey. Indian J Clin Biochem 2020;:1-4. [PMID: 33162692 DOI: 10.1007/s12291-020-00931-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 Aydin A, Cebi G, Demirtas ZE, Erkus H, Kucukay A, Ok M, Sakalli L, Alpdagtas S, Gunduz O, Ustundag CB. Combating COVID-19 with tissue engineering: a review. Emergent Mater 2020;:1-21. [PMID: 33235976 DOI: 10.1007/s42247-020-00138-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Zhang B, Huang W, Zhang S. Clinical Features and Outcomes of Coronavirus Disease 2019 (COVID-19) Patients With Chronic Hepatitis B Virus Infection. Clin Gastroenterol Hepatol. 2020;18:2633-2637. [PMID: 32553905 DOI: 10.1016/j.cgh.2020.06.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
41 Mohamadi M, Goodarzi A, Aryannejad A, Fattahi N, Alizadeh-Khoei M, Miri S, Hekmat H, Payab M, Bodaghabadi M. Geriatric challenges in the new coronavirus disease-19 (COVID-19) pandemic: A systematic review. Med J Islam Repub Iran 2020;34:123. [PMID: 33437719 DOI: 10.34171/mjiri.34.123] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
42 Boddu SK, Aurangabadkar G, Kuchay MS. New onset diabetes, type 1 diabetes and COVID-19.Diabetes Metab Syndr. 2020;14:2211-2217. [PMID: 33395782 DOI: 10.1016/j.dsx.2020.11.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
43 Ristic-Medic D, Petrovic S, Arsic A, Vucic V. Liver disease and COVID-19: The link with oxidative stress, antioxidants and nutrition. World J Gastroenterol 2021; 27(34): 5682-5699 [PMID: 34629794 DOI: 10.3748/wjg.v27.i34.5682] [Reference Citation Analysis]
44 Crimi E, Benincasa G, Figueroa-Marrero N, Galdiero M, Napoli C. Epigenetic susceptibility to severe respiratory viral infections and its therapeutic implications: a narrative review. Br J Anaesth 2020;125:1002-17. [PMID: 32828489 DOI: 10.1016/j.bja.2020.06.060] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
45 Yoo HW, Shin JI, Yon DK, Lee SW. COVID-19 Morbidity and Severity in Patients With Nonalcoholic Fatty Liver Disease in South Korea: A Nationwide Cohort Study. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00813-2. [PMID: 34311112 DOI: 10.1016/j.cgh.2021.07.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Parasa S, Desai M, Thoguluva Chandrasekar V, Patel HK, Kennedy KF, Roesch T, Spadaccini M, Colombo M, Gabbiadini R, Artifon ELA, Repici A, Sharma P. Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3:e2011335. [PMID: 32525549 DOI: 10.1001/jamanetworkopen.2020.11335] [Cited by in Crossref: 133] [Cited by in F6Publishing: 106] [Article Influence: 66.5] [Reference Citation Analysis]
47 Peng H, Chen Z, Wang Y, Ren S, Xu T, Lai X, Wen J, Zhao M, Zeng C, Du L, Zhang Y, Cao L, Hu J, Wei X, Hong T. Systematic Review and Pharmacological Considerations for Chloroquine and Its Analogs in the Treatment for COVID-19. Front Pharmacol. 2020;11:554172. [PMID: 33192503 DOI: 10.3389/fphar.2020.554172] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Dong M, Zhang J, Ma X, Tan J, Chen L, Liu S, Xin Y, Zhuang L. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Biomed Pharmacother 2020;131:110678. [PMID: 32861070 DOI: 10.1016/j.biopha.2020.110678] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 19.5] [Reference Citation Analysis]
49 Chen P, Zhou B. Clinical characteristics of COVID-19 patients with abnormal liver tests. J Hepatol 2020;73:712-3. [PMID: 32348791 DOI: 10.1016/j.jhep.2020.04.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
50 Leo M, Galante A, Pagnamenta A, Ruinelli L, Ponziani F, Gasbarrini A, De Gottardi A. Hepatocellular liver injury in hospitalized patients affected by COVID-19: presence of different risk factors at different time points. Digestive and Liver Disease 2021. [DOI: 10.1016/j.dld.2021.12.014] [Reference Citation Analysis]
51 Zhou H, Huang H, Xie X, Gao J, Wu J, Zhu Y, He W, Liu J, Li A, Xu Y. Development of early warning and rapid response system for patients with novel coronavirus pneumonia (COVID-19): A research protocol. Medicine (Baltimore) 2020;99:e21874. [PMID: 32846843 DOI: 10.1097/MD.0000000000021874] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Roedl K, Jarczak D, Drolz A, Wichmann D, Boenisch O, de Heer G, Burdelski C, Frings D, Sensen B, Nierhaus A, Lütgehetmann M, Kluge S, Fuhrmann V. Severe liver dysfunction complicating course of COVID-19 in the critically ill: multifactorial cause or direct viral effect? Ann Intensive Care 2021;11:44. [PMID: 33721137 DOI: 10.1186/s13613-021-00835-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
53 Rigamonti C, Cittone MG, De Benedittis C, Rizzi E, Casciaro GF, Bellan M, Sainaghi PP, Pirisi M. Rates of Symptomatic SARS-CoV-2 Infection in Patients With Autoimmune Liver Diseases in Northern Italy: A Telemedicine Study. Clin Gastroenterol Hepatol 2020;18:2369-2371.e1. [PMID: 32480009 DOI: 10.1016/j.cgh.2020.05.047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
54 Morgan K, Samuel K, Vandeputte M, Hayes PC, Plevris JN. SARS-CoV-2 Infection and the Liver. Pathogens. 2020;9. [PMID: 32486188 DOI: 10.3390/pathogens9060430] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
55 Xiang F, Sun J, Chen PH, Han P, Zheng H, Cai S, Kirk GD. Early Elevation of Fibrosis-4 Liver Fibrosis Score Is Associated With Adverse Outcomes Among Patients With Coronavirus Disease 2019. Clin Infect Dis 2021;73:e594-601. [PMID: 33909004 DOI: 10.1093/cid/ciaa1710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
56 Lotfi M, Rezaei N. SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences. J Med Virol. 2020;. [PMID: 32492197 DOI: 10.1002/jmv.26123] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 25.5] [Reference Citation Analysis]
57 Hamid S, Alvares da Silva MR, Burak KW, Chen T, Drenth JPH, Esmat G, Gaspar R, LaBrecque D, Lee A, Macedo G, McMahon B, Ning Q, Reau N, Sonderup M, van Leeuwen DJ, Armstrong D, Yurdaydin C. WGO Guidance for the Care of Patients With COVID-19 and Liver Disease. J Clin Gastroenterol. 2021;55:1-11. [PMID: 33230011 DOI: 10.1097/mcg.0000000000001459] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
58 Sivandzadeh GR, Askari H, Safarpour AR, Ejtehadi F, Raeis-Abdollahi E, Vaez Lari A, Abazari MF, Tarkesh F, Bagheri Lankarani K. COVID-19 infection and liver injury: Clinical features, biomarkers, potential mechanisms, treatment, and management challenges. World J Clin Cases 2021; 9(22): 6178-6200 [PMID: 34434987 DOI: 10.12998/wjcc.v9.i22.6178] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Asemota J, Aduli F. The Impact of Nonalcoholic Fatty Liver Disease on the Outcomes of Coronavirus Disease 2019 Infection. Clinical Liver Disease 2022;19:29-31. [DOI: 10.1002/cld.1169] [Reference Citation Analysis]
60 Chen F, Chen W, Chen J, Xu D, Xie W, Wang X, Xie Y. Clinical features and risk factors of COVID-19-associated liver injury and function: A retrospective analysis of 830 cases. Ann Hepatol. 2021;21:100267. [PMID: 33053426 DOI: 10.1016/j.aohep.2020.09.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
61 Drăgănescu AC, Săndulescu O, Bilașco A, Kouris C, Streinu-Cercel A, Luminos M, Streinu-Cercel A. Transient immune hepatitis as post-coronavirus disease complication: A case report. World J Clin Cases 2021; 9(16): 4032-4039 [PMID: 34141763 DOI: 10.12998/wjcc.v9.i16.4032] [Reference Citation Analysis]
62 Kataria S, Sharif A, Ur Rehman A, Ahmed Z, Hanan A. COVID-19 Induced Acute Pancreatitis: A Case Report and Literature Review. Cureus 2020;12:e9169. [PMID: 32802606 DOI: 10.7759/cureus.9169] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
63 Váncsa S, Hegyi PJ, Zádori N, Szakó L, Vörhendi N, Ocskay K, Földi M, Dembrovszky F, Dömötör ZR, Jánosi K, Rakonczay Z Jr, Hartmann P, Horváth T, Erőss B, Kiss S, Szakács Z, Németh D, Hegyi P, Pár G. Pre-existing Liver Diseases and On-Admission Liver-Related Laboratory Tests in COVID-19: A Prognostic Accuracy Meta-Analysis With Systematic Review. Front Med (Lausanne) 2020;7:572115. [PMID: 33282888 DOI: 10.3389/fmed.2020.572115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
64 Lin H, Wu LJ, Guo SQ, Chen RL, Fan JR, Ke B, Pan ZQ. Dynamic monitoring of serum liver function indexes in patients with COVID-19. World J Clin Cases 2021; 9(7): 1554-1562 [PMID: 33728299 DOI: 10.12998/wjcc.v9.i7.1554] [Reference Citation Analysis]
65 Yonter SJ, Alter K, Bartels MN, Bean JF, Brodsky MB, González-Fernández M, Henderson DK, Hoenig H, Russell H, Needham DM, Kumble S, Chan L. What Now for Rehabilitation Specialists? Coronavirus Disease 2019 Questions and Answers. Arch Phys Med Rehabil 2020;101:2233-42. [PMID: 32966809 DOI: 10.1016/j.apmr.2020.09.368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
66 Saeed A, Shorafa E, Shahramian I, Afshari M, Salahifard M, Parooie F. An 11-Year-Old Boy Infected with COVID-19 with Presentation of Acute Liver Failure. Hepat Mon 2020;20. [DOI: 10.5812/hepatmon.104415] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 Hu X, Pan X, Zhou W, Gu X, Shen F, Yang B, Hu Z. Clinical epidemiological analyses of overweight/obesity and abnormal liver function contributing to prolonged hospitalization in patients infected with COVID-19. Int J Obes (Lond) 2020;44:1784-9. [PMID: 32572128 DOI: 10.1038/s41366-020-0634-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
68 Lin J, Bao B, Khurram NA, Halsey K, Choi JW, Wang L, Tran TML, Liao WH, Feldman MD, Zhang PJ, Wu J, Bai HX. Chronic liver disease not a significant comorbid condition for COVID-19. Sci Rep 2021;11:11734. [PMID: 34083670 DOI: 10.1038/s41598-021-91238-8] [Reference Citation Analysis]
69 Kgatle MM, Lawal IO, Mashabela G, Boshomane TMG, Koatale PC, Mahasha PW, Ndlovu H, Vorster M, Rodrigues HG, Zeevaart JR, Gordon S, Moura-Alves P, Sathekge MM. COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks. Front Immunol 2021;12:752380. [PMID: 34691068 DOI: 10.3389/fimmu.2021.752380] [Reference Citation Analysis]
70 Miossec P. [Proinflammatory cytokines and cardio-vascular risk: From myocardial infarction tocytokine storm of COVID-19]. Bull Acad Natl Med 2021;205:43-8. [PMID: 33199926 DOI: 10.1016/j.banm.2020.10.012] [Reference Citation Analysis]
71 Sabe M, Dorsaz O, Huguelet P, Kaiser S. Toxicity of psychotropic drugs in patients with COVID-19: A systematic review. Gen Hosp Psychiatry 2021;70:1-9. [PMID: 33631694 DOI: 10.1016/j.genhosppsych.2021.02.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
72 Zhou F, Xia J, Yuan HX, Sun Y, Zhang Y. Liver injury in COVID-19: Known and unknown. World J Clin Cases 2021; 9(19): 4980-4989 [PMID: 34307548 DOI: 10.12998/wjcc.v9.i19.4980] [Reference Citation Analysis]
73 McGrowder DA, Miller F, Anderson Cross M, Anderson-Jackson L, Bryan S, Dilworth L. Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis. Diseases 2021;9:50. [PMID: 34287285 DOI: 10.3390/diseases9030050] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
74 Ortolan A, Lorenzin M, Felicetti M, Doria A, Ramonda R. Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis. Int J Infect Dis 2020;99:496-504. [PMID: 32800858 DOI: 10.1016/j.ijid.2020.07.076] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
75 Delorey TM, Ziegler CGK, Heimberg G, Normand R, Yang Y, Segerstolpe A, Abbondanza D, Fleming SJ, Subramanian A, Montoro DT, Jagadeesh KA, Dey KK, Sen P, Slyper M, Pita-Juárez YH, Phillips D, Bloom-Ackerman Z, Barkas N, Ganna A, Gomez J, Normandin E, Naderi P, Popov YV, Raju SS, Niezen S, Tsai LT, Siddle KJ, Sud M, Tran VM, Vellarikkal SK, Amir-Zilberstein L, Atri DS, Beechem J, Brook OR, Chen J, Divakar P, Dorceus P, Engreitz JM, Essene A, Fitzgerald DM, Fropf R, Gazal S, Gould J, Grzyb J, Harvey T, Hecht J, Hether T, Jane-Valbuena J, Leney-Greene M, Ma H, McCabe C, McLoughlin DE, Miller EM, Muus C, Niemi M, Padera R, Pan L, Pant D, Pe'er C, Pfiffner-Borges J, Pinto CJ, Plaisted J, Reeves J, Ross M, Rudy M, Rueckert EH, Siciliano M, Sturm A, Todres E, Waghray A, Warren S, Zhang S, Zollinger DR, Cosimi L, Gupta RM, Hacohen N, Hide W, Price AL, Rajagopal J, Tata PR, Riedel S, Szabo G, Tickle TL, Hung D, Sabeti PC, Novak R, Rogers R, Ingber DE, Gordon Jiang Z, Juric D, Babadi M, Farhi SL, Stone JR, Vlachos IS, Solomon IH, Ashenberg O, Porter CBM, Li B, Shalek AK, Villani AC, Rozenblatt-Rosen O, Regev A. A single-cell and spatial atlas of autopsy tissues reveals pathology and cellular targets of SARS-CoV-2. bioRxiv 2021:2021. [PMID: 33655247 DOI: 10.1101/2021.02.25.430130] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
76 Frater JL, Wang T, Lee Y. Laboratory hematologic features of COVID-19 associated liver injury: A systematic review. WJMA 2021;9:192-206. [DOI: 10.13105/wjma.v9.i2.192] [Reference Citation Analysis]
77 Maxwell AJ, Ding J, You Y, Dong Z, Chehade H, Alvero A, Mor Y, Draghici S, Mor G. Identification of key signaling pathways induced by SARS-CoV2 that underlie thrombosis and vascular injury in COVID-19 patients. J Leukoc Biol 2021;109:35-47. [PMID: 33242368 DOI: 10.1002/JLB.4COVR0920-552RR] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
78 Vitiello A, Ferrara F. Plausible Positive Effects of Statins in COVID-19 Patient. Cardiovasc Toxicol 2021;21:781-9. [PMID: 34255300 DOI: 10.1007/s12012-021-09674-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Farshidpour M, Kim D, Junna S, Merchant J. A brief review of liver injury in patients with Corona Virus Disease-19 during the pandemic. Indian J Gastroenterol 2020;39:232-5. [PMID: 32621206 DOI: 10.1007/s12664-020-01068-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Sideris GA, Nikolakea M, Karanikola A, Konstantinopoulou S, Giannis D, Modahl L. Imaging in the COVID-19 era: Lessons learned during a pandemic. WJR 2021;13:193-223. [DOI: 10.4329/wjr.v13.i6.193] [Reference Citation Analysis]
81 Wang X, Lei J, Li Z, Yan L. Potential Effects of Coronaviruses on the Liver: An Update. Front Med (Lausanne) 2021;8:651658. [PMID: 34646834 DOI: 10.3389/fmed.2021.651658] [Reference Citation Analysis]
82 Taneva G, Dimitrov D, Velikova T. Liver dysfunction as a cytokine storm manifestation and prognostic factor for severe COVID-19. World J Hepatol 2021; 13(12): 2005-2012 [DOI: 10.4254/wjh.v13.i12.2005] [Reference Citation Analysis]
83 Guler E, Unal NG, Cinkooglu A, Savas R, Kose T, Pullukcu H, Harman M, Elmas NZ, Ramaiya NH, Ozutemiz AO. Correlation of liver-to-spleen ratio, lung CT scores, clinical, and laboratory findings of COVID-19 patients with two consecutive CT scans. Abdom Radiol (NY) 2021;46:1543-51. [PMID: 33051758 DOI: 10.1007/s00261-020-02805-y] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
84 Pola A, Murthy KS, Santhekadur PK. COVID-19 and gastrointestinal system: A brief review. Biomed J 2021;44:245-51. [PMID: 34130944 DOI: 10.1016/j.bj.2021.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Díaz LA, Idalsoaga F, Cannistra M, Candia R, Cabrera D, Barrera F, Soza A, Graham R, Riquelme A, Arrese M, Leise MD, Arab JP. High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data. World J Gastroenterol 2020; 26(48): 7693-7706 [PMID: 33505145 DOI: 10.3748/wjg.v26.i48.7693] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
86 Yadav DK, Singh A, Zhang Q, Bai X, Zhang W, Yadav RK, Singh A, Zhiwei L, Adhikari VP, Liang T. Involvement of liver in COVID-19: systematic review and meta-analysis. Gut 2021;70:807-9. [PMID: 32669289 DOI: 10.1136/gutjnl-2020-322072] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 35.0] [Reference Citation Analysis]
87 Deng ML, Chen YJ, Yang ML, Liu YW, Chen H, Tang XQ, Yang XF. COVID-19 combined with liver injury: Current challenges and management. World J Clin Cases 2021; 9(15): 3487-3497 [PMID: 34046449 DOI: 10.12998/wjcc.v9.i15.3487] [Reference Citation Analysis]
88 Wang M, Yan W, Qi W, Wu D, Zhu L, Li W, Wang X, Ma K, Ni M, Xu D, Wang H, Chen G, Yu H, Ding H, Xing M, Han M, Luo X, Chen T, Guo W, Xi D, Ning Q. Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China. Hepatol Int. 2020;14:723-732. [PMID: 33026573 DOI: 10.1007/s12072-020-10075-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
89 Mikolasevic I, Bozic D, Pavić T, Ruzic A, Hauser G, Radic M, Radic-Kristo D, Razov-Radas M, Puljiz Z, Milic S. Liver disease in the era of COVID-19: Is the worst yet to come? World J Gastroenterol 2021; 27(36): 6039-6052 [PMID: 34629818 DOI: 10.3748/wjg.v27.i36.6039] [Reference Citation Analysis]
90 Du M, Yang DS, Liu M, Liu J. COVID-19 and Liver dysfunction: Epidemiology, Association and Potential Mechanisms. Clin Res Hepatol Gastroenterol 2021;:101793. [PMID: 34428501 DOI: 10.1016/j.clinre.2021.101793] [Reference Citation Analysis]
91 Chen LZ, Lin ZH, Chen J, Liu SS, Shi T, Xin YN. Can elevated concentrations of ALT and AST predict the risk of 'recurrence' of COVID-19? Epidemiol Infect. 2020;148:e218. [PMID: 32951624 DOI: 10.1017/s0950268820002186] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
92 Zippi M, Fiorino S, Occhigrossi G, Hong W. Hypertransaminasemia in the course of infection with SARS-CoV-2: Incidence and pathogenetic hypothesis. World J Clin Cases 2020; 8(8): 1385-1390 [PMID: 32368531 DOI: 10.12998/wjcc.v8.i8.1385] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
93 Garreta E, Nauryzgaliyeva Z, Montserrat N. Human induced pluripotent stem cell-derived kidney organoids toward clinical implementations. Current Opinion in Biomedical Engineering 2021;20:100346. [DOI: 10.1016/j.cobme.2021.100346] [Reference Citation Analysis]
94 Qu J, Zhu HH, Huang XJ, He GF, Liu JY, Huang JJ, Chen Y, Qu Q, Wu YL, Chen XY, Lu Q. Abnormal Indexes of Liver and Kidney Injury Markers Predict Severity in COVID-19 Patients. Infect Drug Resist 2021;14:3029-40. [PMID: 34408447 DOI: 10.2147/IDR.S321915] [Reference Citation Analysis]
95 Papadopoulos N, Vasileiadi S, Deutsch M. COVID-19 and liver injury: where do we stand? Ann Gastroenterol 2020;33:459-64. [PMID: 32879591 DOI: 10.20524/aog.2020.0522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
96 Kullar R, Patel AP, Saab S. Hepatic Injury in Patients With COVID-19. Journal of Clinical Gastroenterology 2020;54:841-9. [DOI: 10.1097/mcg.0000000000001432] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
97 Puli S, Baig M, Walayat S. Gastrointestinal Symptoms and Elevation in Liver Enzymes in COVID-19 Infection: A Systematic Review and Meta-Analysis. Cureus. 2020;12:e9999. [PMID: 32983698 DOI: 10.7759/cureus.9999] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
98 Omidi N, Forouzannia SK, Poorhosseini H, Tafti SHA, Salehbeigi S, Lotfi-Tokaldany M. Prosthetic heart valves and the COVID-19 pandemic era: What should we be concerned about? J Card Surg 2020;35:2500-5. [PMID: 33043651 DOI: 10.1111/jocs.14707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
99 Vargas-Mendoza N, García-Machorro J, Angeles-Valencia M, Martínez-Archundia M, Madrigal-Santillán EO, Morales-González Á, Anguiano-Robledo L, Morales-González JA. Liver disorders in COVID-19, nutritional approaches and the use of phytochemicals. World J Gastroenterol 2021;27:5630-65. [PMID: 34629792 DOI: 10.3748/wjg.v27.i34.5630] [Reference Citation Analysis]
100 Sharma P, Kumar A. Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19. Diabetes Metab Syndr. 2020;14:825-827. [PMID: 32540736 DOI: 10.1016/j.dsx.2020.06.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
101 Alizadehsani R, Alizadeh Sani Z, Behjati M, Roshanzamir Z, Hussain S, Abedini N, Hasanzadeh F, Khosravi A, Shoeibi A, Roshanzamir M, Moradnejad P, Nahavandi S, Khozeimeh F, Zare A, Panahiazar M, Acharya UR, Islam SMS. Risk factors prediction, clinical outcomes, and mortality in COVID-19 patients. J Med Virol 2021;93:2307-20. [PMID: 33247599 DOI: 10.1002/jmv.26699] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
102 Guo Y, Xia W, Peng X, Shao J. Features Discriminating COVID-19 From Community-Acquired Pneumonia in Pediatric Patients. Front Pediatr 2020;8:602083. [PMID: 33251168 DOI: 10.3389/fped.2020.602083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
103 Lizardo-thiebaud MJ, Cervantes-alvarez E, Limon-de la Rosa N, Tejeda-dominguez F, Palacios-jimenez M, Méndez-guerrero O, Delaye-martinez M, Rodriguez-alvarez F, Romero-morales B, Liu W, Huang CA, Kershenobich D, Navarro-alvarez N. Direct or Collateral Liver Damage in SARS-CoV-2–Infected Patients. Semin Liver Dis 2020;40:321-30. [DOI: 10.1055/s-0040-1715108] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
104 Huang F, Li Y, Leung EL, Liu X, Liu K, Wang Q, Lan Y, Li X, Yu H, Cui L, Luo H, Luo L. A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19). Pharmacol Res 2020;158:104929. [PMID: 32442720 DOI: 10.1016/j.phrs.2020.104929] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 16.5] [Reference Citation Analysis]
105 Fan H, Cai J, Tian A, Li Y, Yuan H, Jiang Z, Yu Y, Ruan L, Hu P, Yue M, Chen N, Li J, Zhu C. Comparison of Liver Biomarkers in 288 COVID-19 Patients: A Mono-Centric Study in the Early Phase of Pandemic. Front Med (Lausanne). 2020;7:584888. [PMID: 33521010 DOI: 10.3389/fmed.2020.584888] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Rasmi Y, Babaei G, Nisar MF, Noreen H, Gholizadeh-Ghaleh Aziz S. Revealed pathophysiological mechanisms of crosslinking interaction of affected vital organs in COVID-19. Comp Clin Path 2021;:1-17. [PMID: 34539310 DOI: 10.1007/s00580-021-03269-2] [Reference Citation Analysis]
107 Anjorin AA, Abioye AI, Asowata OE, Soipe A, Kazeem MI, Adesanya IO, Raji MA, Adesanya M, Oke FA, Lawal FJ, Kasali BA, Omotayo MO. Comorbidities and the COVID-19 pandemic dynamics in Africa. Trop Med Int Health 2021;26:2-13. [PMID: 33012053 DOI: 10.1111/tmi.13504] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
108 Groff A, Kavanaugh M, Ramgobin D, McClafferty B, Aggarwal CS, Golamari R, Jain R. Gastrointestinal Manifestations of COVID-19: A Review of What We Know. Ochsner J 2021;21:177-80. [PMID: 34239378 DOI: 10.31486/toj.20.0086] [Reference Citation Analysis]
109 Al Nemer A. Histopathologic and Autopsy Findings in Patients Diagnosed With Coronavirus Disease 2019 (COVID-19): What We Know So Far Based on Correlation With Clinical, Morphologic and Pathobiological Aspects. Adv Anat Pathol 2020;27:363-70. [PMID: 32732586 DOI: 10.1097/PAP.0000000000000276] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
110 Fiel MI, El Jamal SM, Paniz-Mondolfi A, Gordon RE, Reidy J, Bandovic J, Advani R, Kilaru S, Pourmand K, Ward S, Thung SN, Schiano T. Findings of Severe Hepatic Severe Acute Respiratory Syndrome Coronavirus-2 Infection. Cell Mol Gastroenterol Hepatol. 2021;1-8. [PMID: 32992052 DOI: 10.1016/j.jcmgh.2020.09.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
111 Weber S, Hellmuth JC, Scherer C, Muenchhoff M, Mayerle J, Gerbes AL. Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study. Gut 2021;70:1925-32. [PMID: 33514597 DOI: 10.1136/gutjnl-2020-323800] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 26.0] [Reference Citation Analysis]
112 Premkumar M, Kedarisetty CK. Cytokine Storm of COVID-19 and Its Impact on Patients with and without Chronic Liver Disease. J Clin Transl Hepatol 2021;9:256-64. [PMID: 34007808 DOI: 10.14218/JCTH.2021.00055] [Reference Citation Analysis]
113 Kaneko S, Kurosaki M, Nagata K, Taki R, Ueda K, Hanada S, Takayama K, Suzaki S, Harada N, Sugiyama T, Nagasawa M, Izumi N. Liver injury with COVID-19 based on gastrointestinal symptoms and pneumonia severity. PLoS One. 2020;15:e0241663. [PMID: 33147270 DOI: 10.1371/journal.pone.0241663] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
114 Bernal-Monterde V, Casas-Deza D, Letona-Giménez L, de la Llama-Celis N, Calmarza P, Sierra-Gabarda O, Betoré-Glaria E, Martínez-de Lagos M, Martínez-Barredo L, Espinosa-Pérez M, M Arbones-Mainar J. SARS-CoV-2 Infection Induces a Dual Response in Liver Function Tests: Association with Mortality during Hospitalization. Biomedicines 2020;8:E328. [PMID: 32899640 DOI: 10.3390/biomedicines8090328] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
115 Portincasa P, Krawczyk M, Machill A, Lammert F, Di Ciaula A. Hepatic consequences of COVID-19 infection. Lapping or biting? Eur J Intern Med. 2020;77:18-24. [PMID: 32507608 DOI: 10.1016/j.ejim.2020.05.035] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 17.5] [Reference Citation Analysis]
116 Wang M, Wu T, Zuo Z, You Y, Yang X, Pan L, Hu Y, Luo X, Jiang L, Xia Z, Deng M. Evaluation of current medical approaches for COVID-19: a systematic review and meta-analysis. BMJ Support Palliat Care 2021;11:45-52. [PMID: 32958501 DOI: 10.1136/bmjspcare-2020-002554] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
117 Kumar D, Srivastava S, Rajnikant T, Dawra S, Tevatia M, Mukherjee R. Liver function tests in COVID 19: A retrospective record-based study from a tertiary care centre in urban Maharashtra, India. Medical Journal Armed Forces India 2022. [DOI: 10.1016/j.mjafi.2022.02.010] [Reference Citation Analysis]
118 Chew M, Tang Z, Radcliffe C, Caruana D, Doilicho N, Ciarleglio MM, Deng Y, Garcia-Tsao G. Significant Liver Injury During Hospitalization for COVID-19 Is Not Associated With Liver Insufficiency or Death. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00525-5. [PMID: 34004326 DOI: 10.1016/j.cgh.2021.05.022] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
119 Chan SL, Kudo M. Impacts of COVID-19 on Liver Cancers: During and after the Pandemic. Liver Cancer. 2020;9:491-502. [PMID: 33078127 DOI: 10.1159/000510765] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
120 Becchetti C, Zambelli MF, Pasulo L, Donato MF, Invernizzi F, Detry O, Dahlqvist G, Ciccarelli O, Morelli MC, Fraga M, Svegliati-Baroni G, van Vlierberghe H, Coenraad MJ, Romero MC, de Gottardi A, Toniutto P, Del Prete L, Abbati C, Samuel D, Pirenne J, Nevens F, Dufour JF; COVID-LT group. COVID-19 in an international European liver transplant recipient cohort. Gut 2020;69:1832-40. [PMID: 32571972 DOI: 10.1136/gutjnl-2020-321923] [Cited by in Crossref: 89] [Cited by in F6Publishing: 82] [Article Influence: 44.5] [Reference Citation Analysis]
121 Sahu S, Patil CR, Kumar S, Apparsundaram S, Goyal RK. Role of ACE2-Ang (1-7)-Mas axis in post-COVID-19 complications and its dietary modulation. Mol Cell Biochem 2021. [PMID: 34655418 DOI: 10.1007/s11010-021-04275-2] [Reference Citation Analysis]
122 Mishra K, Naffouj S, Gorgis S, Ibrahim H, Gill S, Fadel R, Chatfield A, Tang A, Salgia R. Liver Injury as a Surrogate for Inflammation and Predictor of Outcomes in COVID-19. Hepatol Commun. 2021;5:24-32. [PMID: 33437898 DOI: 10.1002/hep4.1586] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
123 Chan C, Foster ST, Chan KG, Cacace MJ, Ladd SL, Sandum CT, Wright PT, Volmert B, Yang W, Aguirre A, Li W, Wright NT. Repositioned Drugs for COVID-19-the Impact on Multiple Organs. SN Compr Clin Med 2021;:1-18. [PMID: 33898925 DOI: 10.1007/s42399-021-00874-8] [Reference Citation Analysis]
124 Bertolini A, van de Peppel IP, Bodewes FAJA, Moshage H, Fantin A, Farinati F, Fiorotto R, Jonker JW, Strazzabosco M, Verkade HJ, Peserico G. Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential Pathogenesis. Hepatology 2020;72:1864-72. [PMID: 32702162 DOI: 10.1002/hep.31480] [Cited by in Crossref: 116] [Cited by in F6Publishing: 95] [Article Influence: 58.0] [Reference Citation Analysis]
125 Roman A, Moldovan S, Santini A, Stoian M, Dobru D. Impact of the Severity of Liver Injury in COVID-19 Patients Admitted to an Intensive Care Unit During the SARS-CoV2 Pandemic Outbreak. J Crit Care Med (Targu Mures) 2021;7:211-6. [PMID: 34722924 DOI: 10.2478/jccm-2021-0021] [Reference Citation Analysis]
126 Yang R, Gui X, Zhang Y, Xiong Y. The challenge of resuming classes for young students in Wuhan, China. Expert Rev Respir Med 2020;14:763-6. [PMID: 32375523 DOI: 10.1080/17476348.2020.1761792] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
127 Mendizabal M, Piñero F, Ridruejo E, Anders M, Silveyra MD, Torre A, Montes P, Urzúa A, Pages J, Toro LG, Díaz J, Gonzalez Ballerga E, Miranda-Zazueta G, Peralta M, Gutiérrez I, Michelato D, Venturelli MG, Varón A, Vera-Pozo E, Tagle M, García M, Tassara A, Brutti J, Ruiz García S, Bustios C, Escajadillo N, Macias Y, Higuera-de la Tijera F, Gómez AJ, Dominguez A, Castillo-Barradas M, Contreras F, Scarpin A, Schinoni MI, Toledo C, Girala M, Mainardi V, Sanchez A, Bessone F, Rubinstein F, Silva MO. Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission. Ann Hepatol 2021;21:100298. [PMID: 33359234 DOI: 10.1016/j.aohep.2020.100298] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
128 Lv Y, Zhao X, Wang Y, Zhu J, Ma C, Feng X, Ma Y, Zheng Y, Yang L, Han G, Xie H. Abnormal Liver Function Tests Were Associated With Adverse Clinical Outcomes: An Observational Cohort Study of 2,912 Patients With COVID-19. Front Med (Lausanne) 2021;8:639855. [PMID: 34179034 DOI: 10.3389/fmed.2021.639855] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Faruqui S, Okoli FC, Olsen SK, Feldman DM, Kalia HS, Park JS, Stanca CM, Figueroa Diaz V, Yuan S, Dagher NN, Sarkar SA, Theise ND, Kim S, Shanbhogue K, Jacobson IM. Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications. Am J Gastroenterol 2021;116:1414-25. [PMID: 33993134 DOI: 10.14309/ajg.0000000000001264] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
130 Bennett S, Tafuro J, Mayer J, Darlington D, Wong CW, Muntean EA, Wong N, Mallen C, Kwok CS. Clinical features and outcomes of adults with coronavirus disease 2019: A systematic review and pooled analysis of the literature. Int J Clin Pract 2021;75:e13725. [PMID: 32965728 DOI: 10.1111/ijcp.13725] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
131 Sadeghi A, Eslami P, Dooghaie Moghadam A, Pirsalehi A, Shojaee S, Jalilian Khave L, Sanadgol G, Hasanzade T, Shirini D, Asadzadeh Aghdaei H, Abdi S, Zali MR. Risk factors related to liver injury in non-Intensive Care Unit admitted patients infected with COVID-19: A retrospective study of 102 patients. Caspian J Intern Med. 2020;11:520-526. [PMID: 33425269 DOI: 10.22088/cjim.11.0.520] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
132 El Kassas M, Abdelkader H, Medhat MA. COVID-19 in Egypt: Through crisis to adaptation; a gastroenterologist's perspective. Arab J Gastroenterol. 2020;21:207-210. [PMID: 32798187 DOI: 10.1016/j.ajg.2020.07.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
133 Langford BJ, So M, Raybardhan S, Leung V, Soucy JR, Westwood D, Daneman N, MacFadden DR. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect 2021;27:520-31. [PMID: 33418017 DOI: 10.1016/j.cmi.2020.12.018] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 42.0] [Reference Citation Analysis]
134 Kamin W, Adams O, Kardos P, Matthys H, Meister N, Strassburg CP. Liver Involvement in Acute Respiratory Infections in Children and Adolescents – Results of a Non-interventional Study. Front Pediatr 2022;10:840008. [DOI: 10.3389/fped.2022.840008] [Reference Citation Analysis]
135 Nava-Santana C, Rodríguez-Armida M, Jiménez JV, Vargas-Parra N, León DEA, Campos-Murguia A, Macías-Rodriguez R, Arteaga-Garrido A, Hernández-Villegas AC, Dominguez-Cherit G, Rivero-Sigarroa E, Gamboa-Dominguez A, Gullias-Herrero A, Sifuentes-Osornio J, Uribe-Uribe NO, Morales-Buenrostro LE. Clinicopathologic characteristics of severe COVID-19 patients in Mexico City: A post-mortem analysis using a minimally invasive autopsy approach. PLoS One 2022;17:e0262783. [PMID: 35239660 DOI: 10.1371/journal.pone.0262783] [Reference Citation Analysis]
136 Ye Z, Song B. Liver injury in COVID-19: Diagnosis and associated factors. Liver Int. 2020;40:2040-2041. [PMID: 32359220 DOI: 10.1111/liv.14501] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
137 Kumar A, Kumar P, Dungdung A, Kumar Gupta A, Anurag A, Kumar A. Pattern of liver function and clinical profile in COVID-19: A cross-sectional study of 91 patients. Diabetes Metab Syndr. 2020;14:1951-1954. [PMID: 33039937 DOI: 10.1016/j.dsx.2020.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
138 Mohandas S, Vairappan B. Severe acute respiratory syndrome coronavirus-2 infection and the gut-liver axis. J Dig Dis 2020;21:687-95. [PMID: 33099897 DOI: 10.1111/1751-2980.12951] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
139 Alroomi M, Rajan R, Alsaber A, Pan J, Abdullah M, Abdelnaby H, Aboelhassan W, AlNasrallah N, Al-Bader B, Malhas H, Ramadhan M, Hussein S, Alotaibi N, Al Saleh M, Zhanna KD, Almutairi F. In-hospital mortality in SARS-CoV-2 stratified by gamma-glutamyl transferase levels. J Clin Lab Anal 2022;:e24291. [PMID: 35261080 DOI: 10.1002/jcla.24291] [Reference Citation Analysis]
140 Basu A, Pamreddy A, Singh P, Sharma K. An Adverse Outcomes Approach to Study the Effects of SARS-CoV-2 in 3D Organoid Models. J Mol Biol 2021;:167213. [PMID: 34437890 DOI: 10.1016/j.jmb.2021.167213] [Reference Citation Analysis]
141 Bloom PP, Meyerowitz EA, Reinus Z, Daidone M, Gustafson J, Kim AY, Schaefer E, Chung RT. Liver Biochemistries in Hospitalized Patients With COVID-19. Hepatology 2021;73:890-900. [PMID: 32415860 DOI: 10.1002/hep.31326] [Cited by in Crossref: 92] [Cited by in F6Publishing: 80] [Article Influence: 92.0] [Reference Citation Analysis]
142 Afaghi P, Lapolla MA, Ghandi K. Percutaneous microwave ablation applications for liver tumors: recommendations for COVID-19 patients. Heliyon 2021;7:e06454. [PMID: 33748501 DOI: 10.1016/j.heliyon.2021.e06454] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
143 Pyne JD, Brickman AM. The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline. Neurodegener Dis 2021;21:1-23. [PMID: 34348321 DOI: 10.1159/000518581] [Reference Citation Analysis]
144 Rezasoltani S, Hatami B, Yadegar A, Asadzadeh Aghdaei H, Zali MR. How Patients With Chronic Liver Diseases Succeed to Deal With COVID-19? Front Med (Lausanne) 2020;7:398. [PMID: 32754608 DOI: 10.3389/fmed.2020.00398] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
145 Jefremow A, Neurath MF. SARS-CoV-2 Virus Manifestations in the Gastrointestinal Tract: Therapeutic Implications. Visc Med 2021;37:63-9. [PMID: 33693046 DOI: 10.1159/000513180] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
146 Huang YK, Li YJ, Li B, Wang P, Wang QH. Dysregulated liver function in SARS-CoV-2 infection: Current understanding and perspectives. World J Gastroenterol 2021; 27(27): 4358-4370 [PMID: 34366609 DOI: 10.3748/wjg.v27.i27.4358] [Reference Citation Analysis]
147 Cococcia S, Lenti MV, Santacroce G, Achilli G, Borrelli de Andreis F, Di Sabatino A. Liver-spleen axis dysfunction in COVID-19. World J Gastroenterol 2021; 27(35): 5919-5931 [PMID: 34629809 DOI: 10.3748/wjg.v27.i35.5919] [Reference Citation Analysis]
148 Su YJ, Chang CW, Chen MJ, Lai YC. Impact of COVID-19 on liver. World J Clin Cases 2021; 9(27): 7998-8007 [PMID: 34621856 DOI: 10.12998/wjcc.v9.i27.7998] [Reference Citation Analysis]
149 Bhurwal A, Minacapelli CD, Orosz E, Gupta K, Tait C, Dalal I, Zhang C, Zhao E, Rustgi VK. COVID-19 status quo: Emphasis on gastrointestinal and liver manifestations . World J Gastroenterol 2021; 27(46): 7969-7981 [DOI: 10.3748/wjg.v27.i46.7969] [Reference Citation Analysis]
150 Vinken M. COVID-19 and the liver: an adverse outcome pathway perspective. Toxicology 2021;455:152765. [PMID: 33771662 DOI: 10.1016/j.tox.2021.152765] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
151 Hayashi K, Ito Y, Yamane R, Yoshizaki M, Matsushita K, Kajikawa G, Kozawa T, Mizutani T, Shimizu Y, Nagano K, Tachi K, Yoshioka K, Goto H. The case of a liver-transplant recipient with severe acute respiratory syndrome coronavirus 2 infection who had a favorable outcome. Clin J Gastroenterol 2021;14:842-5. [PMID: 33675512 DOI: 10.1007/s12328-021-01374-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
152 Şahin Özdemirel T, Akkurt ES, Ertan Ö, Gökler ME, Akinci Özyürek B. Complications with moderate-to-severe COVID-19 during hospital admissions in patients with pneumonia. Journal of Health Sciences and Medicine 2021;4:766-71. [DOI: 10.32322/jhsm.946871] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
153 Morelli C, Francavilla M, Stabile Ianora AA, Cozzolino M, Gualano A, Stellacci G, Sacco A, Lorusso F, Pedote P, De Ceglie M, Scardapane A. The Multifaceted COVID-19: CT Aspects of Its Atypical Pulmonary and Abdominal Manifestations and Complications in Adults and Children. A Pictorial Review. Microorganisms 2021;9:2037. [PMID: 34683358 DOI: 10.3390/microorganisms9102037] [Reference Citation Analysis]
154 Shahoei R, Nemati SM, Valiee S. Exploring the Experience of Nurses in Providing Care to Patients With COVID-19: A Qualitative Study. J Nurs Res 2022. [PMID: 35576060 DOI: 10.1097/jnr.0000000000000498] [Reference Citation Analysis]
155 Benedé-Ubieto R, Estévez-Vázquez O, Flores-Perojo V, Macías-Rodríguez RU, Ruiz-Margáin A, Martínez-Naves E, Regueiro JR, Ávila MA, Trautwein C, Bañares R, Bosch J, Cubero FJ, Nevzorova YA. Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2): A Retrospective Single-Center Study from Spain. J Clin Med 2021;10:1039. [PMID: 33802486 DOI: 10.3390/jcm10051039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
156 Taneja SL, Passi M, Bhattacharya S, Schueler SA, Gurram S, Koh C. Social Media and Research Publication Activity During Early Stages of the COVID-19 Pandemic: Longitudinal Trend Analysis. J Med Internet Res 2021;23:e26956. [PMID: 33974550 DOI: 10.2196/26956] [Reference Citation Analysis]
157 Osborne V, Davies M, Lane S, Evans A, Denyer J, Dhanda S, Roy D, Shakir S. Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment. Drug Saf 2020;43:809-21. [PMID: 32578156 DOI: 10.1007/s40264-020-00966-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
158 Tang H, Zhou L, Li X, Kinlaw AC, Yang JY, Moon AM, Barnes EL, Wang T. Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19: a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) data. Int J Clin Pharm 2021;43:1116-22. [PMID: 34328585 DOI: 10.1007/s11096-021-01311-5] [Reference Citation Analysis]
159 Leowattana W. Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients. World J Virol 2021; 10(3): 86-96 [PMID: 34079691 DOI: 10.5501/wjv.v10.i3.86] [Reference Citation Analysis]
160 Ranjbar R, Mahmoodzadeh Hosseini H, Safarpoor Dehkordi F. A Review on Biochemical and Immunological Biomarkers used for Laboratory Diagnosis of SARS-CoV-2 (COVID -19). TOMICROJ 2020;14:290-6. [DOI: 10.2174/1874434602014010290] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
161 Huang R, Zhu L, Wang J, Xue L, Liu L, Yan X, Huang S, Li Y, Yan X, Zhang B, Xu T, Li C, Ji F, Ming F, Zhao Y, Cheng J, Wang Y, Zhao H, Hong S, Chen K, Zhao XA, Zou L, Sang D, Shao H, Guan X, Chen X, Chen Y, Wei J, Zhu C, Wu C. Clinical features of COVID-19 patients with non-alcoholic fatty liver disease. Hepatol Commun 2020. [PMID: 32838108 DOI: 10.1002/hep4.1592] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 7.5] [Reference Citation Analysis]
162 Veleri S. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients. Exp Brain Res 2021. [PMID: 34694467 DOI: 10.1007/s00221-021-06244-z] [Reference Citation Analysis]
163 Ramkissoon R, Wang XJ. The Impact of COVID-19 in Gastroenterology and Hepatology. J Clin Gastroenterol 2021;55:757-65. [PMID: 34420001 DOI: 10.1097/MCG.0000000000001600] [Reference Citation Analysis]
164 Goldberg-Stein S, Fink A, Paroder V, Kobi M, Yee J, Chernyak V. Abdominopelvic CT findings in patients with novel coronavirus disease 2019 (COVID-19). Abdom Radiol (NY) 2020;45:2613-23. [PMID: 32761402 DOI: 10.1007/s00261-020-02669-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 15.0] [Reference Citation Analysis]
165 Campos MR, Schramm JMA, Emmerick ICM, Rodrigues JM, Avelar FG, Pimentel TG. Burden of disease from COVID-19 and its acute and chronic complications: reflections on measurement (DALYs) and prospects for the Brazilian Unified National Health System. Cad Saude Publica 2020;36:e00148920. [PMID: 33146278 DOI: 10.1590/0102-311X00148920] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
166 Neuman MG, Seitz HK, Teschke R, Malnick S, Johnson-davis KL, Cohen LB, German A, Hohmann N, Moreira B, Moussa G, Opris M. Molecular, Viral and Clinical Features of Alcohol- and Non-Alcohol-Induced Liver Injury. CIMB 2022;44:1294-315. [DOI: 10.3390/cimb44030087] [Reference Citation Analysis]
167 Aziz M, Haghbin H, Lee-Smith W, Goyal H, Nawras A, Adler DG. Gastrointestinal predictors of severe COVID-19: systematic review and meta-analysis. Ann Gastroenterol 2020;33:615-30. [PMID: 33162738 DOI: 10.20524/aog.2020.0527] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
168 Spoto S, Valeriani E, Riva E, De Cesaris M, Tonini G, Vincenzi B, Locorriere L, Beretta Anguissola G, Lauria Pantano A, Brando E, Costantino S, Ciccozzi M, Angeletti S. A Staphylococcus aureus Coinfection on a COVID-19 Pneumonia in a Breast Cancer Patient. Int J Gen Med 2020;13:729-33. [PMID: 33061542 DOI: 10.2147/IJGM.S261760] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
169 Kulkarni AV, Kumar P, Tevethia HV, Premkumar M, Arab JP, Candia R, Talukdar R, Sharma M, Qi X, Rao PN, Reddy DN. Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19. Aliment Pharmacol Ther. 2020;52:584-599. [PMID: 32638436 DOI: 10.1111/apt.15916] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 29.5] [Reference Citation Analysis]
170 Caramaschi S, Kapp ME, Miller SE, Eisenberg R, Johnson J, Epperly G, Maiorana A, Silvestri G, Giannico GA. Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review. Mod Pathol 2021;34:1614-33. [PMID: 34031537 DOI: 10.1038/s41379-021-00814-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
171 Hwaiz R, Merza M, Hamad B, HamaSalih S, Mohammed M, Hama H. Evaluation of hepatic enzymes activities in COVID-19 patients. Int Immunopharmacol 2021;97:107701. [PMID: 33930704 DOI: 10.1016/j.intimp.2021.107701] [Reference Citation Analysis]
172 Chu H, Bai T, Chen L, Hu L, Xiao L, Yao L, Zhu R, Niu X, Li Z, Zhang L, Han C, Song S, He Q, Zhao Y, Zhu Q, Chen H, Schnabl B, Yang L, Hou X. Multicenter Analysis of Liver Injury Patterns and Mortality in COVID-19. Front Med (Lausanne). 2020;7:584342. [PMID: 33195339 DOI: 10.3389/fmed.2020.584342] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
173 Letelier P, Encina N, Morales P, Riffo A, Silva H, Riquelme I, Guzmán N. Role of biochemical markers in the monitoring of COVID-19 patients. J Med Biochem 2021;40:115-28. [PMID: 33776561 DOI: 10.5937/jomb0-29341] [Reference Citation Analysis]
174 Song JE, Kang MK, Lee YR, Lee CH, Park JG, Kweon YO, Tak WY, Park SY, Jang SY, Hwang JS, Jang BK, Jang WY, Suh JI, Chung WJ, Kim BS; Daegu-Gyeongbuk Liver Study Group (DGLSG). Multicenter Analysis of Clinical Features and Prognosis of COVID-19 Patients with Hepatic Impairment. Gut Liver 2021;15:606-15. [PMID: 33782216 DOI: 10.5009/gnl20267] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
175 Vitrone M, Mele F, Durante-Mangoni E, Zampino R. Drugs and liver injury: a not to be overlooked binomial in COVID-19. J Chemother 2021;:1-14. [PMID: 34644236 DOI: 10.1080/1120009X.2021.1988203] [Reference Citation Analysis]
176 Taneja SL, Passi M, Bhattacharya S, Schueler SA, Gurram S, Koh C. COVID-19: An analysis of social media and research publication activity during the early stages of the pandemic. medRxiv 2020:2020. [PMID: 33398297 DOI: 10.1101/2020.12.20.20248517] [Reference Citation Analysis]
177 Ghoshal UC, Ghoshal U, Dhiman RK. Gastrointestinal and Hepatic Involvement in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Review. J Clin Exp Hepatol 2020;10:622-8. [PMID: 32837095 DOI: 10.1016/j.jceh.2020.06.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
178 Delgado A, Stewart S, Urroz M, Rodríguez A, Borobia AM, Akatbach-Bousaid I, González-Muñoz M, Ramírez E. Characterisation of Drug-Induced Liver Injury in Patients with COVID-19 Detected by a Proactive Pharmacovigilance Program from Laboratory Signals. J Clin Med 2021;10:4432. [PMID: 34640458 DOI: 10.3390/jcm10194432] [Reference Citation Analysis]
179 Lv XH, Yang JL, Deng K. The Topic of COVID-19-Related Liver Injury Needs More Rigorous Research. Clin Gastroenterol Hepatol. 2020;18:2848. [PMID: 32371168 DOI: 10.1016/j.cgh.2020.04.073] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
180 DeMartino AW, Rose JJ, Amdahl MB, Dent MR, Shah FA, Bain W, McVerry BJ, Kitsios GD, Tejero J, Gladwin MT. No evidence of hemoglobin damage by SARS-CoV-2 infection. Haematologica 2020;105:2769-73. [PMID: 33054129 DOI: 10.3324/haematol.2020.264267] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
181 Wang T, Smith DA, Campbell C, Harris S, Salih H, Várnai KA, Woods K, Noble T, Freeman O, Moysova Z, Marjot T, Webb GJ, Davies J, Barnes E, Matthews PC. Longitudinal analysis of the utility of liver biochemistry in hospitalised COVID-19 patients as prognostic markers. Hepatol Commun 2021. [PMID: 34222741 DOI: 10.1002/hep4.1739] [Reference Citation Analysis]
182 Harman K, Verma A, Cook J, Radia T, Zuckerman M, Deep A, Dhawan A, Gupta A. Ethnicity and COVID-19 in children with comorbidities. Lancet Child Adolesc Health 2020;4:e24-5. [PMID: 32473663 DOI: 10.1016/S2352-4642(20)30167-X] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 12.5] [Reference Citation Analysis]
183 Sideris GA, Nikolakea M, Karanikola AE, Konstantinopoulou S, Giannis D, Modahl L. Imaging in the COVID-19 era: Lessons learned during a pandemic. World J Radiol 2021; 13(6): 192-222 [PMID: 34249239 DOI: 10.4329/wjr.v13.i6.192] [Reference Citation Analysis]
184 Ye J, Hua M, Zhu F. Machine Learning Algorithms are Superior to Conventional Regression Models in Predicting Risk Stratification of COVID-19 Patients. Risk Manag Healthc Policy 2021;14:3159-66. [PMID: 34349576 DOI: 10.2147/RMHP.S318265] [Reference Citation Analysis]
185 [DOI: 10.1101/2020.10.22.20216317] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
186 Sharma P, Kumar A, Anikhindi S, Bansal N, Singla V, Shivam K, Arora A. Effect of COVID-19 on Pre-existing Liver disease: What Hepatologist Should Know? J Clin Exp Hepatol 2021;11:484-93. [PMID: 33398223 DOI: 10.1016/j.jceh.2020.12.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
187 Lei HY, Ding YH, Nie K, Dong YM, Xu JH, Yang ML, Liu MQ, Wei L, Nasser MI, Xu LY, Zhu P, Zhao MY. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver. Biomed Pharmacother 2021;133:111064. [PMID: 33378966 DOI: 10.1016/j.biopha.2020.111064] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
188 Delgado-Gonzalez P, Gonzalez-Villarreal CA, Roacho-Perez JA, Quiroz-Reyes AG, Islas JF, Delgado-Gallegos JL, Arellanos-Soto D, Galan-Huerta KA, Garza-Treviño EN. Inflammatory effect on the gastrointestinal system associated with COVID-19. World J Gastroenterol 2021; 27(26): 4160-4171 [PMID: 34326616 DOI: 10.3748/wjg.v27.i26.4160] [Reference Citation Analysis]
189 Wong GL, Wong VW, Thompson A, Jia J, Hou J, Lesmana CRA, Susilo A, Tanaka Y, Chan WK, Gane E, Ong-Go AK, Lim SG, Ahn SH, Yu ML, Piratvisuth T, Chan HL;  Asia-Pacific Working Group for Liver Derangement during the COVID-19 Pandemic. Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement. Lancet Gastroenterol Hepatol. 2020;5:776-787. [PMID: 32585136 DOI: 10.1016/s2468-1253(20)30190-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
190 Rosen HR, O'Connell C, Nadim MK, DeClerck B, Sheibani S, DePasquale E, Sanossian N, Blodget E, Angell T. Extrapulmonary manifestations of severe acute respiratory syndrome coronavirus-2 infection. J Med Virol 2021;93:2645-53. [PMID: 33090515 DOI: 10.1002/jmv.26595] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
191 Sodeifian F, Seyedalhosseini ZS, Kian N, Eftekhari M, Najari S, Mirsaeidi M, Farsi Y, Nasiri MJ. Drug-Induced Liver Injury in COVID-19 Patients: A Systematic Review. Front Med (Lausanne) 2021;8:731436. [PMID: 34616757 DOI: 10.3389/fmed.2021.731436] [Reference Citation Analysis]
192 Cichoż-Lach H, Michalak A. Liver injury in the era of COVID-19. World J Gastroenterol 2021; 27(5): 377-390 [PMID: 33584070 DOI: 10.3748/wjg.v27.i5.377] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
193 Han MW, Wang M, Xu MY, Qi WP, Wang P, Xi D. Clinical features and potential mechanism of coronavirus disease 2019-associated liver injury. World J Clin Cases 2021; 9(3): 528-539 [PMID: 33553391 DOI: 10.12998/wjcc.v9.i3.528] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
194 Hosseini-Fard SR, Dehpour AR, Emamgholipour S, Golestani A. Naltrexone protects against BDL-induced cirrhosis in Wistar rats by attenuating thrombospondin-1 and enhancing antioxidant defense system via Nrf-2. Life Sci 2022;300:120576. [PMID: 35487305 DOI: 10.1016/j.lfs.2022.120576] [Reference Citation Analysis]
195 Laali A, Tabibzadeh A, Esghaei M, Yousefi P, Soltani S, Ajdarkosh H, Mosavi-Jarrahi A, Karbalaie Niya MH. Liver Function Tests Profile in COVID-19 Patients at the Admission Time: A Systematic Review of Literature and Conducted Researches. Adv Biomed Res 2020;9:74. [PMID: 33912490 DOI: 10.4103/abr.abr_73_20] [Reference Citation Analysis]
196 Ferron PJ, Gicquel T, Mégarbane B, Clément B, Fromenty B. Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury? Biochimie 2020;179:266-74. [PMID: 32891697 DOI: 10.1016/j.biochi.2020.08.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
197 Shaffaf T, Ghafar-Zadeh E. COVID-19 Diagnostic Strategies Part II: Protein-Based Technologies. Bioengineering (Basel) 2021;8:54. [PMID: 33925032 DOI: 10.3390/bioengineering8050054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
198 Abe K, Yamamoto T, Matsumoto K, Kikuchi K, Miura R, Tachizawa N, Asaoka Y, Takezawa T, Matsunaga N, Obi S, Tanaka A. Clinical Features and Liver Injury in Patients with COVID-19 in the Japanese Population. Intern Med. 2020;59:2353-2358. [PMID: 32999264 DOI: 10.2169/internalmedicine.5777-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
199 Gulati A, Pomeranz C, Qamar Z, Thomas S, Frisch D, George G, Summer R, DeSimone J, Sundaram B. A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic. Am J Med Sci 2020;360:5-34. [PMID: 32620220 DOI: 10.1016/j.amjms.2020.05.006] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 20.0] [Reference Citation Analysis]
200 Chen L, Huang S, Yang J, Cheng X, Shang Z, Lu H, Cheng J. Clinical characteristics in patients with SARS-CoV-2/HBV co-infection. J Viral Hepat. 2020;27:1504-1507. [PMID: 32668494 DOI: 10.1111/jvh.13362] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 7.5] [Reference Citation Analysis]
201 Abdullatif H, Elakel W, Baroudy S, El-karaksy H, Mogahed EA. Covid-19 pandemic in egyptian children with liver diseases: incidence and impact on health care service delivery in a low/middle income country. Arab Journal of Gastroenterology 2022. [DOI: 10.1016/j.ajg.2022.01.002] [Reference Citation Analysis]
202 Kalal CR, Joshi H, Kumar V, Gopal D, Rathod D, Shukla A, Gianchandani T, Bhatt C. Clinical Significance of Liver Function Abnormality in Patients with COVID-19: A Single-center Experience from Western India. J Clin Transl Hepatol 2021;9:878-88. [PMID: 34966651 DOI: 10.14218/JCTH.2020.00099] [Reference Citation Analysis]
203 Currier EE, Dabaja M, Jafri SM. Elevated liver enzymes portends a higher rate of complication and death in SARS-CoV-2. World J Hepatol 2021; 13(9): 1181-1189 [PMID: 34630884 DOI: 10.4254/wjh.v13.i9.1181] [Reference Citation Analysis]
204 Memel ZN, Lee JJ, Foulkes AS, Chung RT, Thaweethai T, Bloom PP. Association of Statins and 28-Day Mortality in Patients Hospitalized with SARS CoV-2 Infection. J Infect Dis 2021:jiab539. [PMID: 34665852 DOI: 10.1093/infdis/jiab539] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
205 Tang Y, Wu P, Li L, Xu W, Jiang J. Mesenchymal Stem Cells and Their Small Extracellular Vesicles as Crucial Immunological Efficacy for Hepatic Diseases. Front Immunol 2022;13:880523. [DOI: 10.3389/fimmu.2022.880523] [Reference Citation Analysis]
206 Vitale G, Gitto S, Marra F, Morelli MC. From advanced disease to transplantation: an overview of the liver at the time of COVID-19 pandemic. Intern Emerg Med 2021. [PMID: 34245423 DOI: 10.1007/s11739-021-02801-0] [Reference Citation Analysis]
207 Xu W, Sun NN, Gao HN, Chen ZY, Yang Y, Ju B, Tang LL. Risk factors analysis of COVID-19 patients with ARDS and prediction based on machine learning. Sci Rep 2021;11:2933. [PMID: 33536460 DOI: 10.1038/s41598-021-82492-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
208 Wu J, Yuan X, Wang B, Gu R, Li W, Xiang X, Tang L, Sun H. Severe Acute Respiratory Syndrome Coronavirus 2: From Gene Structure to Pathogenic Mechanisms and Potential Therapy. Front Microbiol 2020;11:1576. [PMID: 32719672 DOI: 10.3389/fmicb.2020.01576] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
209 Xie P, Ma W, Tang H, Liu D. Severe COVID-19: A Review of Recent Progress With a Look Toward the Future. Front Public Health 2020;8:189. [PMID: 32574292 DOI: 10.3389/fpubh.2020.00189] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 17.0] [Reference Citation Analysis]
210 Trypsteen W, Van Cleemput J, Snippenberg WV, Gerlo S, Vandekerckhove L. On the whereabouts of SARS-CoV-2 in the human body: A systematic review. PLoS Pathog 2020;16:e1009037. [PMID: 33125439 DOI: 10.1371/journal.ppat.1009037] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 20.0] [Reference Citation Analysis]
211 Zhu C, Sun B, Zhang X, Zhang B. Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019. Front Pharmacol 2020;11:1327. [PMID: 32973534 DOI: 10.3389/fphar.2020.01327] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
212 Zhang J, Dong X, Liu G, Gao Y. Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality. Clinic Rev Allerg Immunol. [DOI: 10.1007/s12016-022-08921-5] [Reference Citation Analysis]
213 Iqbal Z, Ho JH, Adam S, France M, Syed A, Neely D, Rees A, Khatib R, Cegla J, Byrne C, Qureshi N, Capps N, Ferns G, Payne J, Schofield J, Nicholson K, Datta D, Pottle A, Halcox J, Krentz A, Durrington P, Soran H; Heart UK's Medical Scientific and Research Committee. Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK. Atherosclerosis 2020;313:126-36. [PMID: 33045618 DOI: 10.1016/j.atherosclerosis.2020.09.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
214 Abdel‐moneim A. COVID ‐19 complications on the digestive system and liver: A current clinical and pathophysiological approach. Adv in Digestive Med. [DOI: 10.1002/aid2.13260] [Reference Citation Analysis]
215 Bohn MK, Hall A, Sepiashvili L, Jung B, Steele S, Adeli K. Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression. Physiology (Bethesda). 2020;35:288-301. [PMID: 32783610 DOI: 10.1152/physiol.00019.2020] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 16.0] [Reference Citation Analysis]
216 Mohammed A, Paranji N, Chen PH, Niu B. COVID-19 in Chronic Liver Disease and Liver Transplantation: A Clinical Review. J Clin Gastroenterol 2021;55:187-94. [PMID: 33394628 DOI: 10.1097/MCG.0000000000001481] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
217 Schwab P, DuMont Schütte A, Dietz B, Bauer S. Clinical Predictive Models for COVID-19: Systematic Study. J Med Internet Res 2020;22:e21439. [PMID: 32976111 DOI: 10.2196/21439] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 12.0] [Reference Citation Analysis]
218 Deng G, Zeng F, Zhang L, Chen H, Chen X, Yin M. Characteristics of pregnant patients with COVID-19 and liver injury. J Hepatol 2020;73:989-91. [PMID: 32569609 DOI: 10.1016/j.jhep.2020.06.022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
219 Atere TG, Oladokun OO, Osuntokun OS, Adedokun KI, Fatoki JO, Olawumi SA, Tokunbo OS, Obembe OO, Afolabi OS. Modulatory effects of phenolics extract of Costus afer leaves on cadmium induced nephrotoxicity and hepatoxicity in Wistar rats. Toxicol Environ Health Sci . [DOI: 10.1007/s13530-022-00125-w] [Reference Citation Analysis]
220 Vaidya T, Nanivadekar A, Patel R. Imaging spectrum of abdominal manifestations of COVID-19. World J Radiol 2021; 13(6): 157-170 [PMID: 34249237 DOI: 10.4329/wjr.v13.i6.157] [Reference Citation Analysis]
221 Wu Y, Ma Z, Guo X, Li H, Tang Y, Meng H, Yu H, Peng C, Chu G, Wang X, Teng Y, Zhang Q, Zhu T, Wang B, Tong Z, Feng R, Zhao H, Lu H, Qi X. Characteristics and in-hospital outcomes of COVID-19 patients with abnormal liver biochemical tests. Ann Hepatol 2021;24:100349. [PMID: 33862291 DOI: 10.1016/j.aohep.2021.100349] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
222 Vespa E, Pugliese N, Colapietro F, Aghemo A. Stay (GI) Healthy: COVID-19 and Gastrointestinal Manifestations. Tech Innov Gastrointest Endosc. 2021;23:179-189. [PMID: 33521703 DOI: 10.1016/j.tige.2021.01.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
223 Park YJ, Farooq J, Cho J, Sadanandan N, Cozene B, Gonzales-Portillo B, Saft M, Borlongan MC, Borlongan MC, Shytle RD, Willing AE, Garbuzova-Davis S, Sanberg PR, Borlongan CV. Fighting the War Against COVID-19 via Cell-Based Regenerative Medicine: Lessons Learned from 1918 Spanish Flu and Other Previous Pandemics. Stem Cell Rev Rep 2021;17:9-32. [PMID: 32789802 DOI: 10.1007/s12015-020-10026-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
224 Jin Z, Liu JY, Feng R, Ji L, Jin ZL, Li HB. Drug treatment of coronavirus disease 2019 (COVID-19) in China. Eur J Pharmacol 2020;883:173326. [PMID: 32598953 DOI: 10.1016/j.ejphar.2020.173326] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
225 Amanollahi A, Sotoodeh Ghorbani S, Basir Ghafouri H, Afrashteh S, Hashemi Nazari SS. Which criteria were used to describe patients with COVID-19? A systematic review and meta analysis of clinical, laboratory, and imaging features. Med J Islam Repub Iran 2021;35:112. [PMID: 34956958 DOI: 10.47176/mjiri.35.112] [Reference Citation Analysis]
226 Xu W, Huang C, Fei L, Li Q, Chen L. Dynamic Changes in Liver Function Tests and Their Correlation with Illness Severity and Mortality in Patients with COVID-19: A Retrospective Cohort Study. Clin Interv Aging 2021;16:675-85. [PMID: 33911856 DOI: 10.2147/CIA.S303629] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
227 Hundt MA, Deng Y, Ciarleglio MM, Nathanson MH, Lim JK. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network. Hepatology 2020;72:1169-76. [PMID: 32725890 DOI: 10.1002/hep.31487] [Cited by in Crossref: 105] [Cited by in F6Publishing: 84] [Article Influence: 52.5] [Reference Citation Analysis]
228 Wan D, Du T, Hong W, Chen L, Que H, Lu S, Peng X. Neurological complications and infection mechanism of SARS-COV-2. Signal Transduct Target Ther 2021;6:406. [PMID: 34815399 DOI: 10.1038/s41392-021-00818-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
229 Fu Y, Zhu R, Bai T, Han P, He Q, Jing M, Xiong X, Zhao X, Quan R, Chen C, Zhang Y, Tao M, Yi J, Tian D, Yan W. Clinical Features of Patients Infected With Coronavirus Disease 2019 With Elevated Liver Biochemistries: A Multicenter, Retrospective Study. Hepatology 2021;73:1509-20. [PMID: 32602604 DOI: 10.1002/hep.31446] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 27.0] [Reference Citation Analysis]
230 Ning Q, Wu D, Wang X, Xi D, Chen T, Chen G, Wang H, Lu H, Wang M, Zhu L, Hu J, Liu T, Ma K, Han M, Luo X. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication. Signal Transduct Target Ther 2022;7:57. [PMID: 35197452 DOI: 10.1038/s41392-022-00907-1] [Reference Citation Analysis]
231 Zhao W, Zhang X, Zhu F, Jiang X. Dynamic Changes of Liver Function Indexes in Patients with Different Clinical Types of COVID-19. IJGM 2022;Volume 15:877-84. [DOI: 10.2147/ijgm.s347291] [Reference Citation Analysis]
232 Ghimire S, Sharma S, Patel A, Budhathoki R, Chakinala R, Khan H, Lincoln M, Georgeston M. Diarrhea Is Associated with Increased Severity of Disease in COVID-19: Systemic Review and Metaanalysis. SN Compr Clin Med 2021;:1-8. [PMID: 33432303 DOI: 10.1007/s42399-020-00662-w] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
233 Chen P, Zhou B. Clinical Characteristics of COVID-19 in Patients With Liver Injury. Clin Gastroenterol Hepatol. 2020;18:2846-2847. [PMID: 32407783 DOI: 10.1016/j.cgh.2020.04.043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
234 Cui H, Wu F, Fan Z, Cheng X, Cheng J, Fan M. The effects of renin-angiotensin system inhibitors (RASI) in coronavirus disease (COVID-19) with hypertension: A retrospective, single-center trial. Med Clin (Barc) 2020;155:295-8. [PMID: 32747012 DOI: 10.1016/j.medcli.2020.06.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
235 Nasa P, Alexander G. COVID-19 and the liver: What do we know so far? World J Hepatol 2021;13:522-32. [PMID: 34131467 DOI: 10.4254/wjh.v13.i5.522] [Reference Citation Analysis]
236 Ghoda A, Ghoda M. Liver Injury in COVID-19 Infection: A Systematic Review. Cureus. 2020;12:e9487. [PMID: 32879813 DOI: 10.7759/cureus.9487] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
237 Boregowda U, Aloysius MM, Perisetti A, Gajendran M, Bansal P, Goyal H. Serum Activity of Liver Enzymes Is Associated With Higher Mortality in COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2020;7:431. [PMID: 32793616 DOI: 10.3389/fmed.2020.00431] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
238 Wu H, Liu S, Luo H, Chen M. Progress in the Clinical Features and Pathogenesis of Abnormal Liver Enzymes in Coronavirus Disease 2019. J Clin Transl Hepatol 2021;9:239-46. [PMID: 34007806 DOI: 10.14218/JCTH.2020.00126] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
239 Aghbash PS, Eslami N, Shirvaliloo M, Baghi HB. Viral coinfections in COVID-19. J Med Virol 2021;93:5310-22. [PMID: 34032294 DOI: 10.1002/jmv.27102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
240 Garrido M, Pereira Guedes T, Alves Silva J, Falcão D, Novo I, Archer S, Rocha M, Maia L, Sarmento-Castro R, Pedroto I. Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19. GE Port J Gastroenterol 2021;158:1-12. [PMID: 34192127 DOI: 10.1159/000513593] [Reference Citation Analysis]
241 Zarifian A, Zamiri Bidary M, Arekhi S, Rafiee M, Gholamalizadeh H, Amiriani A, Ghaderi MS, Khadem-Rezaiyan M, Amini M, Ganji A. Gastrointestinal and hepatic abnormalities in patients with confirmed COVID-19: A systematic review and meta-analysis. J Med Virol 2021;93:336-50. [PMID: 32681674 DOI: 10.1002/jmv.26314] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
242 Taylor R 3rd, Mallon D. COVID-19 and Pediatric Gastroenterology. Pediatr Clin North Am 2021;68:1157-69. [PMID: 34736582 DOI: 10.1016/j.pcl.2021.07.003] [Reference Citation Analysis]
243 Ye J, Zhang X, Zhu F, Tang Y. Application of a prediction model with laboratory indexes in the risk stratification of patients with COVID-19. Exp Ther Med 2021;21:182. [PMID: 33488791 DOI: 10.3892/etm.2021.9613] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
244 Malik SUF, Chowdhury PA, Hakim A, Islam MS, Alam MJ, Azad AK. Blood biochemical parameters for assessment of COVID-19 in diabetic and non-diabetic subjects: a cross-sectional study. Int J Environ Health Res 2021;:1-14. [PMID: 33504213 DOI: 10.1080/09603123.2021.1879741] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
245 Rachel JB, Gururaj N, Smitha T, Daniel TD, Harishini BS, Rosaian AS. Innovative diagnostic approach and investigation trends in COVID19-A systematic review. J Oral Maxillofac Pathol 2020;24:421-36. [PMID: 33967476 DOI: 10.4103/jomfp.jomfp_395_20] [Reference Citation Analysis]
246 Di Giorgio A, Hartleif S, Warner S, Kelly D. COVID-19 in Children With Liver Disease. Front Pediatr 2021;9:616381. [PMID: 33777864 DOI: 10.3389/fped.2021.616381] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
247 Karmakar D, Lahiri B, Ranjan P, Chatterjee J, Lahiri P, Sengupta S. Road Map to Understanding SARS-CoV-2 Clinico-Immunopathology and COVID-19 Disease Severity. Pathogens 2020;10:5. [PMID: 33374748 DOI: 10.3390/pathogens10010005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
248 Tan AS, Nerurkar SN, Tan WCC, Goh D, Lai CPT, Poh Sheng Yeong J. The Virological, Immunological, and Imaging Approaches for COVID-19 Diagnosis and Research. SLAS Technol 2020;25:522-44. [PMID: 32808850 DOI: 10.1177/2472630320950248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
249 Yadav J, Goel G, Purwar S, Saigal S, Tandon A, Joshi A, Patel B, Js S, S M, Singh J, Shankar P, Arora A, Singh S. Clinical, Virological, and Pathological Profile of Patients Who Died of COVID-19: An Autopsy-Based Study From India. Cureus. [DOI: 10.7759/cureus.23538] [Reference Citation Analysis]
250 Su HY, Hsu YC. Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives . World J Clin Cases 2021; 9(13): 2951-2968 [PMID: 33969082 DOI: 10.12998/wjcc.v9.i13.2951] [Reference Citation Analysis]
251 Zhao JN, Fan Y, Wu SD. Liver injury in COVID-19: A minireview. World J Clin Cases 2020; 8(19): 4303-4310 [PMID: 33083389 DOI: 10.12998/wjcc.v8.i19.4303] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
252 Perisetti A, Gajendran M, Mann R, Elhanafi S, Goyal H. COVID-19 extrapulmonary illness - special gastrointestinal and hepatic considerations. Dis Mon. 2020;66:101064. [PMID: 32807535 DOI: 10.1016/j.disamonth.2020.101064] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
253 Pellegrini JR Jr, Sabbula B, Russe-Russe JR, Munshi RF, Meshoyrer D, Sajid N, Gutierrez A, Munnangi S, Szydziak E, Akella J. A Retrospective Analysis of COVID-19-infected Patients with Acute Hepatitis who Develop Acute Liver Failure in a Safety Net Hospital. BMJ Open Gastroenterol 2021;8:e000738. [PMID: 34810216 DOI: 10.1136/bmjgast-2021-000738] [Reference Citation Analysis]
254 Garrido I, Liberal R, Macedo G. Review article: COVID-19 and liver disease-what we know on 1st May 2020. Aliment Pharmacol Ther. 2020;52:267-275. [PMID: 32402090 DOI: 10.1111/apt.15813] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 31.0] [Reference Citation Analysis]
255 Gan Q, Gong B, Sun M, Cao Z, Zheng Y, Zhang Y, Wen P, Shen Y, Hong L, Hou T, Jia Y, Li W, Li H, Xie Q. A High Percentage of Patients Recovered From COVID-19 but Discharged With Abnormal Liver Function Tests. Front Physiol 2021;12:642922. [PMID: 33815147 DOI: 10.3389/fphys.2021.642922] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
256 Rowaiye AB, Okpalefe OA, Onuh Adejoke O, Ogidigo JO, Hannah Oladipo O, Ogu AC, Oli AN, Olofinase S, Onyekwere O, Rabiu Abubakar A, Jahan D, Islam S, Dutta S, Haque M. Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications. J Inflamm Res 2021;14:1487-510. [PMID: 33889008 DOI: 10.2147/JIR.S301784] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
257 Akin H, Kurt R, Tufan F, Swi A, Ozaras R, Tahan V, Hammoud G. Newly Reported Studies on the Increase in Gastrointestinal Symptom Prevalence withCOVID-19 Infection: A Comprehensive Systematic Review and Meta-Analysis. Diseases 2020;8:E41. [PMID: 33182651 DOI: 10.3390/diseases8040041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
258 Abdelrahman MM, Abdel-Baset AA, Younis MA, Mahmoud MG, Shafik NS. Liver function test abnormalities in COVID-19 patients and factors affecting them - a retrospective study. Clin Exp Hepatol 2021;7:297-304. [PMID: 34712832 DOI: 10.5114/ceh.2021.109225] [Reference Citation Analysis]
259 Tsatsakis A, Calina D, Falzone L, Petrakis D, Mitrut R, Siokas V, Pennisi M, Lanza G, Libra M, Doukas SG, Doukas PG, Kavali L, Bukhari A, Gadiparthi C, Vageli DP, Kofteridis DP, Spandidos DA, Paoliello MMB, Aschner M, Docea AO. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19. Food Chem Toxicol 2020;146:111769. [PMID: 32979398 DOI: 10.1016/j.fct.2020.111769] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 24.0] [Reference Citation Analysis]
260 Zhan GF, Wang Y, Yang N, Luo AL, Li SY. Digestive system involvement of infections with SARS-CoV-2 and other coronaviruses: Clinical manifestations and potential mechanisms. World J Gastroenterol 2021; 27(7): 561-575 [PMID: 33642829 DOI: 10.3748/wjg.v27.i7.561] [Reference Citation Analysis]
261 Gupta M, Manek G, Dombrowski K, Maiwall R. Newer developments in viral hepatitis: Looking beyond hepatotropic viruses. World J Meta-Anal 2021; 9(6): 522-542 [DOI: 10.13105/wjma.v9.i6.522] [Reference Citation Analysis]
262 Chivukula RR, Maley JH, Dudzinski DM, Hibbert K, Hardin CC. Evidence-Based Management of the Critically Ill Adult With SARS-CoV-2 Infection. J Intensive Care Med 2021;36:18-41. [PMID: 33111601 DOI: 10.1177/0885066620969132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
263 Balderramo D, Mattos AZ, Mulqui V, Chiesa T, Plácido-Damián Z, Abarca J, Bolomo A, Carlino Y, Bombassaro IZ, Wiltgen D, Castillo LT, Díaz K, Acuña J, Manero E, Prieto J, Carrera E, Díaz-Ferrer J, Debes JD. Abnormal Liver Tests during Hospitalization Predict Mortality in Patients with COVID-19: A Multicenter Study from South America. Can J Gastroenterol Hepatol 2021;2021:1622533. [PMID: 34621710 DOI: 10.1155/2021/1622533] [Reference Citation Analysis]
264 Medetalibeyoglu A, Catma Y, Senkal N, Ormeci A, Cavus B, Kose M, Bayramlar OF, Yildiz G, Akyuz F, Kaymakoglu S, Tukek T. The effect of liver test abnormalities on the prognosis of COVID-19. Ann Hepatol 2020;19:614-21. [PMID: 32920162 DOI: 10.1016/j.aohep.2020.08.068] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
265 Hushmandi K, Bokaie S, Hashemi M, Moghadam ER, Raei M, Hashemi F, Bagheri M, Habtemariam S, Nabavi SM. A review of medications used to control and improve the signs and symptoms of COVID-19 patients. Eur J Pharmacol 2020;887:173568. [PMID: 32956644 DOI: 10.1016/j.ejphar.2020.173568] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
266 Chang JPE, Wong YJ, Yang WL, Lim KBL, Tan PS, Ho GH, Yip BCH, Li JW, Chong CH, Ong DEH, Chua TS, Vu CKF, Gwee KA, Ang TL, Tan CK. Chapter of Gastroenterologists professional guidance for management of patients with liver disease in Singapore during the COVID-19 pandemic. Singapore Med J 2020;61:619-23. [PMID: 32349198 DOI: 10.11622/smedj.2020069] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
267 Kim SW, Jeon JH, Moon JS, Kim MK. High Fibrosis-4 Index Is Related with Worse Clinical Outcome in Patients with Coronavirus Disease 2019 and Diabetes Mellitus: A Multicenter Observational Study. Endocrinol Metab (Seoul) 2021;36:800-9. [PMID: 34418914 DOI: 10.3803/EnM.2021.1040] [Reference Citation Analysis]
268 Ding ZY, Li GX, Chen L, Shu C, Song J, Wang W, Wang YW, Chen Q, Jin GN, Liu TT, Liang JN, Zhu P, Zhu W, Li Y, Zhang BH, Feng H, Zhang WG, Yin ZY, Yu WK, Yang Y, Zhang HQ, Tang ZP, Wang H, Hu JB, Liu JH, Yin P, Chen XP, Zhang B; Tongji Multidisciplinary Team for Treating COVID-19 (TTTC). Association of liver abnormalities with in-hospital mortality in patients with COVID-19. J Hepatol 2021;74:1295-302. [PMID: 33347952 DOI: 10.1016/j.jhep.2020.12.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 25] [Article Influence: 8.5] [Reference Citation Analysis]
269 Malik P, Patel U, Mehta D, Patel N, Kelkar R, Akrmah M, Gabrilove JL, Sacks H. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Evid Based Med 2021;26:107-8. [PMID: 32934000 DOI: 10.1136/bmjebm-2020-111536] [Cited by in Crossref: 33] [Cited by in F6Publishing: 49] [Article Influence: 16.5] [Reference Citation Analysis]
270 Bourgonje AR, Abdulle AE, Timens W, Hillebrands JL, Navis GJ, Gordijn SJ, Bolling MC, Dijkstra G, Voors AA, Osterhaus AD, van der Voort PH, Mulder DJ, van Goor H. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol. 2020;251:228-248. [PMID: 32418199 DOI: 10.1002/path.5471] [Cited by in Crossref: 284] [Cited by in F6Publishing: 280] [Article Influence: 142.0] [Reference Citation Analysis]
271 Wu J, Song S, Cao HC, Li LJ. Liver diseases in COVID-19: Etiology, treatment and prognosis. World J Gastroenterol 2020;26:2286-93. [PMID: 32476793 DOI: 10.3748/wjg.v26.i19.2286] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 46] [Article Influence: 29.5] [Reference Citation Analysis]
272 Krishnan A, Prichett L, Tao X, Alqahtani SA, Hamilton JP, Mezey E, Strauss AT, Kim A, Potter JJ, Chen PH, Woreta TA. Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients. World J Gastroenterol 2022; 28(5): 570-587 [DOI: 10.3748/wjg.v28.i5.570] [Reference Citation Analysis]
273 Li W, Ma Q, Wang X, Tang M, Lin J, Xiao B. The characteristics of two patients coinfected with SARS-CoV-2 and HIV in Wuhan, China. J Med Virol 2021;93:85-8. [PMID: 32519763 DOI: 10.1002/jmv.26155] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
274 Abu-Hammad O, Dar-Odeh N, Abu-Hammad A, Althagafi N, Eshky R, Abu-Hammad S. Long-Term Complications of Coronavirus Disease 2019; What the Oral Surgeon Needs To Know. J Craniofac Surg 2021;32:e652-5. [PMID: 34705368 DOI: 10.1097/SCS.0000000000007665] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
275 Frager SZ, Szymanski J, Schwartz JM, Massoumi HS, Kinkhabwala M, Wolkoff AW. Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis. Hepatol Commun. 2020;5:424-433. [PMID: 33681677 DOI: 10.1002/hep4.1648] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
276 Silva FAFD, de Brito BB, Santos MLC, Marques HS, da Silva Júnior RT, de Carvalho LS, de Sousa Cruz S, Rocha GR, Correa Santos GL, de Souza KC, Maciel RGA, Lopes DS, Silva NOE, Oliveira MV, de Melo FF. Transmission of severe acute respiratory syndrome coronavirus 2 via fecal-oral: Current knowledge. World J Clin Cases 2021; 9(28): 8280-8294 [PMID: 34754839 DOI: 10.12998/wjcc.v9.i28.8280] [Reference Citation Analysis]
277 Ahmad A, Ishtiaq SM, Khan JA, Aslam R, Ali S, Arshad MI. COVID-19 and comorbidities of hepatic diseases in a global perspective. World J Gastroenterol 2021; 27(13): 1296-1310 [PMID: 33833483 DOI: 10.3748/wjg.v27.i13.1296] [Reference Citation Analysis]
278 Liu J, Wang T, Cai Q, Huang D, Sun L, He Q, Wang FS, Chen J. Acute Kidney Injury and Early Predictive Factors in COVID-19 Patients. Front Med (Lausanne) 2021;8:604242. [PMID: 34322497 DOI: 10.3389/fmed.2021.604242] [Reference Citation Analysis]
279 Padmaprakash K, Thareja S, Raman N, Sowmya Karantha C, Muthukrishnan J, Vardhan V. “Does Transaminitis Predict Severity and Mortality in COVID 19 Patients?”. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.01.004] [Reference Citation Analysis]
280 Phipps MM, Verna EC. Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic. Liver Transpl 2021;27:1312-25. [PMID: 34096188 DOI: 10.1002/lt.26194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
281 Shoaib MH, Ahmed FR, Sikandar M, Yousuf RI, Saleem MT. A Journey From SARS-CoV-2 to COVID-19 and Beyond: A Comprehensive Insight of Epidemiology, Diagnosis, Pathogenesis, and Overview of the Progress into Its Therapeutic Management. Front Pharmacol 2021;12:576448. [PMID: 33732150 DOI: 10.3389/fphar.2021.576448] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
282 Takayama K. In Vitro and Animal Models for SARS-CoV-2 research. Trends Pharmacol Sci 2020;41:513-7. [PMID: 32553545 DOI: 10.1016/j.tips.2020.05.005] [Cited by in Crossref: 76] [Cited by in F6Publishing: 67] [Article Influence: 38.0] [Reference Citation Analysis]
283 Sahu T, Pande B, PL M, Verma HK. Liver dysfunction during COVID-19 pandemic: Contributing role of associated factors in disease progression and severity. World J Hepatol 2022; 14(6): 1099-1110 [DOI: 10.4254/wjh.v14.i6.1099] [Reference Citation Analysis]
284 Li X, Qiu Q, Li M, Lin H, Cao S, Wang Q, Chen Z, Jiang W, Zhang W, Huang Y, Luo H, Luo L. Chemical composition and pharmacological mechanism of ephedra-glycyrrhiza drug pair against coronavirus disease 2019 (COVID-19). Aging (Albany NY) 2021;13:4811-30. [PMID: 33581688 DOI: 10.18632/aging.202622] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
285 Harapan H, Fajar JK, Supriono S, Soegiarto G, Wulandari L, Seratin F, Prayudi NG, Dewi DP, Monica Elsina MT, Atamou L, Wiranata S, Aprianto DP, Friska E, Sari Firdaus DF, Alaidin M, Wardhani FA, Husnah M, Hidayati NW, Hendriyanti Y, Wardani K, Evatta A, Manugan RA, Pradipto W, Rahmawati A, Tamara F, Mahendra AI, Nainu F, Santoso B, Irawan Primasatya CA, Tjionganata N, Budiman HA. The prevalence, predictors and outcomes of acute liver injury among patients with COVID-19: A systematic review and meta-analysis. Rev Med Virol 2021;:e2304. [PMID: 34643006 DOI: 10.1002/rmv.2304] [Reference Citation Analysis]
286 Mokhtari T, Hassani F, Ghaffari N, Ebrahimi B, Yarahmadi A, Hassanzadeh G. COVID-19 and multiorgan failure: A narrative review on potential mechanisms. J Mol Histol. 2020;51:613-628. [PMID: 33011887 DOI: 10.1007/s10735-020-09915-3] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 30.5] [Reference Citation Analysis]
287 Wang J, Zhu L, Xue L, Liu L, Yan X, Huang S, Zhang B, Xu T, Li C, Ji F, Ming F, Zhao Y, Cheng J, Shao H, Chen K, Zhao XA, Sang D, Zhao H, Guan X, Chen X, Chen Y, Liu J, Huang R, Zhu C, Wu C. Risk factors of liver injury in patients with coronavirus disease 2019 in Jiangsu, China: A retrospective, multi-center study. J Med Virol. 2020;. [PMID: 33174624 DOI: 10.1002/jmv.26663] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
288 Rabiee A, Sadowski B, Adeniji N, Perumalswami PV, Nguyen V, Moghe A, Latt NL, Kumar S, Aloman C, Catana AM, Bloom PP, Chavin KD, Carr RM, Dunn W, Chen VL, Aby ES, Debes JD, Dhanasekaran R; COLD Consortium. Liver Injury in Liver Transplant Recipients With Coronavirus Disease 2019 (COVID-19): U.S. Multicenter Experience. Hepatology 2020;72:1900-11. [PMID: 32964510 DOI: 10.1002/hep.31574] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 17.5] [Reference Citation Analysis]
289 Shao S, Zhao Z, Wang F, Chang D, Liu Y, Liu S, Xu X, Li X, Jiang C, Tang Z. Risk factors associated with disease aggravation among 126 hospitalized patients with COVID-19 in different places in China: A retrospective observational study. Medicine (Baltimore) 2020;99:e22971. [PMID: 33157938 DOI: 10.1097/MD.0000000000022971] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
290 Jakhmola S, Indari O, Kashyap D, Varshney N, Rani A, Sonkar C, Baral B, Chatterjee S, Das A, Kumar R, Jha HC. Recent updates on COVID-19: A holistic review. Heliyon 2020;6:e05706. [PMID: 33324769 DOI: 10.1016/j.heliyon.2020.e05706] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
291 Sanz Segura P, Arguedas Lázaro Y, Mostacero Tapia S, Cabrera Chaves T, Sebastián Domingo JJ. Involvement of the digestive system in covid-19. A review. Gastroenterol Hepatol 2020;43:464-71. [PMID: 32859408 DOI: 10.1016/j.gastrohep.2020.06.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
292 Benkirane H, Heikel J, Laamiri FZ, Bouziani A, Lahmam H, Al-Jawaldeh A, El Haloui N, Ennibi K, Akhtar-Khan N, El Fahime EM, Obtel M, Barkat A, Aguenaou H. Study of Clinical and Biological Characteristics of Moroccan Covid-19 Patients With and Without Olfactory and/or Gustatory Dysfunction. Front Physiol 2020;11:595005. [PMID: 33329044 DOI: 10.3389/fphys.2020.595005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
293 Vazzana N, Dipaola F, Ognibene S. Procalcitonin and secondary bacterial infections in COVID-19: association with disease severity and outcomes. Acta Clin Belg 2022;77:268-72. [PMID: 32966166 DOI: 10.1080/17843286.2020.1824749] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 19.0] [Reference Citation Analysis]
294 Levy E, Stintzi A, Cohen A, Desjardins Y, Marette A, Spahis S. Critical appraisal of the mechanisms of gastrointestinal and hepatobiliary infection by COVID-19. Am J Physiol Gastrointest Liver Physiol 2021;321:G99-G112. [PMID: 34009033 DOI: 10.1152/ajpgi.00106.2021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
295 Kim D, Adeniji N, Latt N, Kumar S, Bloom PP, Aby ES, Perumalswami P, Roytman M, Li M, Vogel AS, Catana AM, Wegermann K, Carr RM, Aloman C, Chen V, Rabiee A, Sadowski B, Nguyen V, Dunn W, Chavin K, Zhou K, Lizaola-Mayo B, Moghe A, Debes J, Lee TH, Branch A, Viveiros K, Chan W, Chascsa D, Kwo P, Dhanasekaran R. Predictors of Outcomes of COVID-19 in Patients with Chronic Liver Disease: US Multi-center Study. Clin Gastroenterol Hepatol. 2020;. [PMID: 32950749 DOI: 10.1016/j.cgh.2020.09.027] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 16.0] [Reference Citation Analysis]
296 Martinez MA, Franco S. Impact of COVID-19 in Liver Disease Progression. Hepatol Commun 2021. [PMID: 34222744 DOI: 10.1002/hep4.1745] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
297 Meng Z, Guo S, Zhou Y, Li M, Wang M, Ying B. Applications of laboratory findings in the prevention, diagnosis, treatment, and monitoring of COVID-19. Signal Transduct Target Ther 2021;6:316. [PMID: 34433805 DOI: 10.1038/s41392-021-00731-z] [Reference Citation Analysis]
298 Anirvan P, Bharali P, Gogoi M, Thuluvath PJ, Singh SP, Satapathy SK. Liver injury in COVID-19: The hepatic aspect of the respiratory syndrome — what we know so far. World J Hepatol 2020; 12(12): 1182-1197 [PMID: 33442447 DOI: 10.4254/wjh.v12.i12.1182] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
299 Mohamed DZ, Ghoneim MES, Abu-Risha SES, Abdelsalam RA, Farag MA. Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management. World J Gastroenterol 2021; 27(28): 4504-4535 [PMID: 34366621 DOI: 10.3748/wjg.v27.i28.4504] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
300 Nayak B, Lal G, Kumar S, Das CJ, Saraya A, Shalimar. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases. Front Cell Infect Microbiol 2021;11:753249. [PMID: 34760721 DOI: 10.3389/fcimb.2021.753249] [Reference Citation Analysis]
301 Xiang D, Ren X, Chen Q, Yu H, Li X, Liu D. Association of ACEI/ARB, inflammatory cytokines, and antiviral drugs with liver dysfunction in patients with hypertension and COVID-19. Clin Exp Hypertens 2021;43:305-10. [PMID: 33356606 DOI: 10.1080/10641963.2020.1867160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
302 Ali ET, Sajid Jabbar A, Al Ali HS, Shaheen Hamadi S, Jabir MS, Albukhaty S, Li J. Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients. International Journal of Inflammation 2022;2022:1-11. [DOI: 10.1155/2022/5735546] [Reference Citation Analysis]
303 Sirinawasatien A, Chantarojanasiri T, Ekpanyapong S, Tivatunsakul N, Luvira V. Coronavirus disease 2019 gastrointestinal and liver manifestations in adults: A review. JGH Open 2021;5:1257-65. [PMID: 34816011 DOI: 10.1002/jgh3.12671] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
304 Higuera-de-la-Tijera F, Servín-Caamaño A, Reyes-Herrera D, Flores-López A, Robiou-Vivero EJA, Martínez-Rivera F, Galindo-Hernández V, Rosales-Salyano VH, Casillas-Suárez C, Chapa-Azuela O, Chávez-Morales A, Jiménez-Bobadilla B, Hernández-Medel ML, Orozco-Zúñiga B, Zacarías-Ezzat JR, Camacho S, Pérez-Hernández JL. The Age-AST-D Dimer (AAD) Regression Model Predicts Severe COVID-19 Disease. Dis Markers 2021;2021:6658270. [PMID: 33791045 DOI: 10.1155/2021/6658270] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
305 Malik A, Thanekar U, Amarachintha S, Mourya R, Nalluri S, Bondoc A, Shivakumar P. "Complimenting the Complement": Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma. Front Oncol 2020;10:627701. [PMID: 33718121 DOI: 10.3389/fonc.2020.627701] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
306 Salık F, Uzundere O, Bıçak M, Akelma H, Akgündüz M, Korhan Z, Kandemir D, Kaçar CK. Liver function as a predictor of mortality in COVID-19: A retrospective study. Ann Hepatol 2021;:100553. [PMID: 34624543 DOI: 10.1016/j.aohep.2021.100553] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
307 Ossami Saidy RR, Globke B, Pratschke J, Schoening W, Eurich D. Successful implementation of preventive measures leads to low relevance of SARS-CoV-2 in liver transplant patients: Observations from a German outpatient department. Transpl Infect Dis 2020;22:e13363. [PMID: 32516847 DOI: 10.1111/tid.13363] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
308 Ramachandran P, Perisetti A, Gajendran M, Chakraborti A, Narh JT, Goyal H. Increased Serum Aminotransferase Activity and Clinical Outcomes in Coronavirus Disease 2019. J Clin Exp Hepatol. 2020;10:533-539. [PMID: 32837096 DOI: 10.1016/j.jceh.2020.06.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
309 Su YJ, Chang CW, Chen MJ, Lai YC. Impact of COVID-19 on liver. World J Clin Cases 2021;9:7998-8007. [PMID: 34621856 DOI: 10.12998/wjcc.v9.i27.7998] [Reference Citation Analysis]
310 Tsibouris P, Ekmektzoglou K, Agorogianni A, Kalantzis C, Theofanopoulou A, Toumbelis K, Petrogiannopoulos L, Poutakidis C, Goggaki S, Braimakis I, Vlachou E, Pouliakis A, Apostolopoulos P. Gastrointestinal involvement in COVID-19 patients: a retrospective study from a Greek COVID-19 referral hospital. Ann Gastroenterol 2020;33:465-72. [PMID: 32879592 DOI: 10.20524/aog.2020.0514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
311 Witenko CJ, Littlefield AJ, Abedian S, An A, Barie PS, Berger K. The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019. Ann Pharmacother 2021;:10600280211017315. [PMID: 33985368 DOI: 10.1177/10600280211017315] [Reference Citation Analysis]
312 Sikander M, Malik S, Rodriguez A, Yallapu MM, Narula AS, Satapathy SK, Dhevan V, Chauhan SC, Jaggi M. Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction. Molecules 2020;25:E5905. [PMID: 33322162 DOI: 10.3390/molecules25245905] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
313 Kayaaslan B, Guner R. COVID-19 and the liver: A brief and core review. World J Hepatol 2021; 13(12): 2013-2023 [DOI: 10.4254/wjh.v13.i12.2013] [Reference Citation Analysis]
314 Chen LY, Chu HK, Bai T, Tu SJ, Wei Y, Li ZL, Hu LL, Zhu R, Zhang L, Han CQ, Xiao L, He Q, Song J, Liu WH, Zhu QJ, Chen H, Yang L, Hou XH. Liver damage at admission is an independent prognostic factor for COVID-19. J Dig Dis. 2020;21:512-518. [PMID: 32713118 DOI: 10.1111/1751-2980.12925] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
315 Lopes-Pacheco M, Silva PL, Cruz FF, Battaglini D, Robba C, Pelosi P, Morales MM, Caruso Neves C, Rocco PRM. Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies. Front Physiol 2021;12:593223. [PMID: 33584343 DOI: 10.3389/fphys.2021.593223] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
316 Zhan K, Liao S, Li J, Bai Y, Lv L, Yu K, Qiu L, Li C, Yuan G, Zhang A, Mei Z. Risk factors in patients with COVID-19 developing severe liver injury during hospitalisation. Gut 2021;70:628-9. [PMID: 32571973 DOI: 10.1136/gutjnl-2020-321913] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
317 Sahu T, Mehta A, Ratre YK, Jaiswal A, Vishvakarma NK, Bhaskar LVKS, Verma HK. Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings. World J Gastroenterol 2021; 27(6): 449-469 [PMID: 33642821 DOI: 10.3748/wjg.v27.i6.449] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
318 Luglio M, Tannuri U, de Carvalho WB, Bastos KLM, Rodriguez IS, Johnston C, Delgado AF. COVID-19 and Liver Damage: Narrative Review and Proposed Clinical Protocol for Critically ill Pediatric Patients. Clinics (Sao Paulo) 2020;75:e2250. [PMID: 33206767 DOI: 10.6061/clinics/2020/e2250] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
319 Lv XH, Yang JL, Deng K. Lopinavir-Ritonavir and Liver Involvement in Patients With COVID-19. Am J Gastroenterol 2021;116:1099. [PMID: 33136567 DOI: 10.14309/ajg.0000000000001043] [Reference Citation Analysis]
320 Roy HS, Singh R, Ghosh D. SARS-CoV-2 and tissue damage: current insights and biomaterial-based therapeutic strategies. Biomater Sci 2021;9:2804-24. [PMID: 33666206 DOI: 10.1039/d0bm02077j] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
321 Pawlowska J, Lebensztejn DM, Jankowska I. Coronavirus Disease 2019-Liver Injury-Literature Review and Guidelines Based on the Recommendations of Hepatological Societies. Pediatr Gastroenterol Hepatol Nutr. 2021;24:119-126. [PMID: 33833967 DOI: 10.5223/pghn.2021.24.2.119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
322 Ali FEM, Mohammedsaleh ZM, Ali MM, Ghogar OM. Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges. World J Gastroenterol 2021; 27(15): 1531-1552 [PMID: 33958841 DOI: 10.3748/wjg.v27.i15.1531] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
323 Hong JK, Chopra S, Kahn JA, Kim B, Khemichian S. Autoimmune hepatitis triggered by COVID-19. Intern Med J 2021;51:1182-3. [PMID: 34278694 DOI: 10.1111/imj.15420] [Reference Citation Analysis]
324 Westheim AJF, Bitorina AV, Theys J, Shiri-Sverdlov R. COVID-19 infection, progression, and vaccination: Focus on obesity and related metabolic disturbances. Obes Rev 2021;22:e13313. [PMID: 34269511 DOI: 10.1111/obr.13313] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
325 Xiang TD, Zheng X. Interaction between hepatitis B virus and SARS-CoV-2 infections. World J Gastroenterol 2021; 27(9): 782-793 [PMID: 33727770 DOI: 10.3748/wjg.v27.i9.782] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
326 Batalha PN, Forezi LSM, Lima CGS, Pauli FP, Boechat FCS, de Souza MCBV, Cunha AC, Ferreira VF, da Silva FC. Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches. Bioorg Chem 2021;106:104488. [PMID: 33261844 DOI: 10.1016/j.bioorg.2020.104488] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
327 Simonis A, Theobald SJ, Fätkenheuer G, Rybniker J, Malin JJ. A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2. EMBO Mol Med 2021;13:e13105. [PMID: 33015938 DOI: 10.15252/emmm.202013105] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
328 Ahmad Z, Goswami S, Paneerselvam A, Kabilan K, Chowdhury H, Roy A, Guleria R, Soni KD, Baruah U, Das CJ. Imaging of Coronavirus Disease 2019 Infection From Head to Toe: A Primer for the Radiologist. Curr Probl Diagn Radiol 2021:S0363-0188(21)00113-4. [PMID: 34330569 DOI: 10.1067/j.cpradiol.2021.06.015] [Reference Citation Analysis]
329 Butt JH, Gerds TA, Schou M, Kragholm K, Phelps M, Havers-Borgersen E, Yafasova A, Gislason GH, Torp-Pedersen C, Køber L, Fosbøl EL. Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study. BMJ Open 2020;10:e044421. [PMID: 33277291 DOI: 10.1136/bmjopen-2020-044421] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 13.5] [Reference Citation Analysis]
330 Zhang SS, Dong L, Wang GM, Tian Y, Ye XF, Zhao Y, Liu ZY, Zhai JY, Zhao ZL, Wang JH, Zhang HM, Li XL, Wu CX, Yang CT, Yang LJ, Du HX, Wang H, Ge QG, Xiu DR, Shen N. Progressive liver injury and increased mortality risk in COVID-19 patients: A retrospective cohort study in China. World J Gastroenterol 2021; 27(9): 835-853 [PMID: 33727773 DOI: 10.3748/wjg.v27.i9.835] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
331 Cai Y, Ye LP, Song YQ, Mao XL, Wang L, Jiang YZ, Que WT, Li SW. Liver injury in COVID-19: Detection, pathogenesis, and treatment. World J Gastroenterol 2021; 27(22): 3022-3036 [PMID: 34168405 DOI: 10.3748/wjg.v27.i22.3022] [Reference Citation Analysis]
332 Frater JL, Wang T, Lee YS. Laboratory hematologic features of COVID-19 associated liver injury: A systematic review. World J Meta-Anal 2021; 9(2): 193-207 [DOI: 10.13105/wjma.v9.i2.193] [Reference Citation Analysis]
333 Singhai A, Pavan GS, Panda S. Evaluation of liver function in symptomatic COVID-19 patients. J Family Med Prim Care 2021;10:3252-6. [PMID: 34760739 DOI: 10.4103/jfmpc.jfmpc_2527_20] [Reference Citation Analysis]
334 Shousha HI, Ramadan A, Lithy R, El-Kassas M. Patterns of liver profile disturbance in patients with COVID-19 . World J Clin Cases 2022; 10(7): 2063-2071 [DOI: 10.12998/wjcc.v10.i7.2063] [Reference Citation Analysis]
335 Law MF, Ho R, Law KWT, Cheung CKM. Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases. World J Hepatol 2021; 13(12): 1850-1874 [DOI: 10.4254/wjh.v13.i12.1850] [Reference Citation Analysis]
336 Ye Z, Song B. COVID-19 Related Liver Injury: Call for International Consensus. Clin Gastroenterol Hepatol. 2020;18:2848-2851. [PMID: 32425707 DOI: 10.1016/j.cgh.2020.05.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
337 Omar AS, Kaddoura R, Orabi B, Hanoura S. Impact of COVID-19 pandemic on liver, liver diseases, and liver transplantation programs in intensive care units. World J Hepatol 2021; 13(10): 1215-1233 [PMID: 34786163 DOI: 10.4254/wjh.v13.i10.1215] [Reference Citation Analysis]
338 Tsatsakis A, Calina D, Falzone L, Petrakis D, Mitrut R, Siokas V, Pennisi M, Lanza G, Libra M, Doukas SG, Doukas PG, Kavali L, Bukhari A, Gadiparthi C, Vageli DP, Kofteridis DP, Spandidos DA, Paoliello MMB, Aschner M, Docea AO. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19. Food Chem Toxicol 2020;146:111769. [PMID: 32979398 DOI: 10.1016/j.fct.2020.111769] [Reference Citation Analysis]
339 Bayram M, Yildirim O, Ozmen RS, Soylu B, Dundar AS, Koksal AR, Akarsu M, Kumbasar A, Tabak O. Elevation of Serum Transaminase Levels Due to Favipiravir Use in the Treatment of COVID-19. Cureus 2021;13:e18166. [PMID: 34703696 DOI: 10.7759/cureus.18166] [Reference Citation Analysis]
340 Gameil MA, Marzouk RE, Elsebaie AH, Rozaik SE. Long-term clinical and biochemical residue after COVID-19 recovery. Egypt Liver J 2021;11:74. [PMID: 34777873 DOI: 10.1186/s43066-021-00144-1] [Reference Citation Analysis]
341 Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, Hou C, Wang H, Liu J, Xu Y, Cao Z, Gao Z. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care. 2020;24:422. [PMID: 32660650 DOI: 10.1186/s13054-020-03120-0] [Cited by in Crossref: 157] [Cited by in F6Publishing: 153] [Article Influence: 78.5] [Reference Citation Analysis]
342 Cai Q, Xu L, Chen J. Reply to: "Liver tests abnormalities in COVID-19: trick or treat?". J Hepatol 2020;73:1277-8. [PMID: 32634547 DOI: 10.1016/j.jhep.2020.06.041] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
343 Panchal D, Kataria J, Patel K, Crowe K, Pai V, Azizogli AR, Kadian N, Sanyal S, Roy A, Dodd-O J, Acevedo-Jake AM, Kumar VA. Peptide-Based Inhibitors for SARS-CoV-2 and SARS-CoV. Adv Ther (Weinh) 2021;:2100104. [PMID: 34514085 DOI: 10.1002/adtp.202100104] [Reference Citation Analysis]
344 Bollipo S, Kapuria D, Rabiee A, Ben-Yakov G, Lui RN, Lee HW, Kumar G, Siau K, Turnes J, Dhanasekaran R. One world, one pandemic, many guidelines: management of liver diseases during COVID-19. Gut 2020;69:1369-72. [PMID: 32499304 DOI: 10.1136/gutjnl-2020-321553] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 15.5] [Reference Citation Analysis]
345 Teodorescu M. An Overview of a Year with COVID-19: What We Know? ELECTRON J GEN MED 2021;18:em286. [DOI: 10.29333/ejgm/9765] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
346 Karnik M, Beeraka NM, Uthaiah CA, Nataraj SM, Bettadapura ADS, Aliev G, Madhunapantula SV. A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development. Mol Neurobiol 2021. [PMID: 34089508 DOI: 10.1007/s12035-021-02399-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
347 Dawood RM, Salum GM, El-Meguid MA. The Impact of COVID-19 on Liver Injury: COVID-19 and Liver Injury. Am J Med Sci 2021:S0002-9629(21)00400-6. [PMID: 34752738 DOI: 10.1016/j.amjms.2021.11.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
348 Yan H, Lu S, Chen L, Wang Y, Liu Q, Li D, Yan X, Yan J. Multiple organ injury on admission predicts in-hospital mortality in patients with COVID-19. J Med Virol 2021;93:1652-64. [PMID: 32949175 DOI: 10.1002/jmv.26534] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
349 Sun F, Kou H, Wang S, Lu Y, Zhao H, Li W, Zhou Q, Jiang Q, Cheng Y, Yang K, Zhuo L, Xu Y, Wu D, Zhan S, Cheng H. An analytical study of drug utilization, disease progression, and adverse events among 165 COVID-19 patients. Ann Transl Med 2021;9:306. [PMID: 33708933 DOI: 10.21037/atm-20-4960] [Reference Citation Analysis]
350 Makar M, John Pisano T, Minacapelli CD, Rustgi V. Gastrointestinal Findings in a Patient With COVID-19. ACG Case Rep J 2020;7:e00392. [PMID: 32637437 DOI: 10.14309/crj.0000000000000392] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]